|
US6515009B1
(en)
|
1991-09-27 |
2003-02-04 |
Neorx Corporation |
Therapeutic inhibitor of vascular smooth muscle cells
|
|
US5811447A
(en)
|
1993-01-28 |
1998-09-22 |
Neorx Corporation |
Therapeutic inhibitor of vascular smooth muscle cells
|
|
US6395494B1
(en)
|
1993-05-13 |
2002-05-28 |
Neorx Corporation |
Method to determine TGF-β
|
|
US6251920B1
(en)
|
1993-05-13 |
2001-06-26 |
Neorx Corporation |
Prevention and treatment of cardiovascular pathologies
|
|
US6306421B1
(en)
|
1992-09-25 |
2001-10-23 |
Neorx Corporation |
Therapeutic inhibitor of vascular smooth muscle cells
|
|
US6277410B1
(en)
*
|
1992-10-08 |
2001-08-21 |
Supratek Pharma Inc. |
Copolymer compositions for oral delivery
|
|
FR2697752B1
(fr)
*
|
1992-11-10 |
1995-04-14 |
Rhone Poulenc Rorer Sa |
Compositions antitumorales contenant des dérivés du taxane.
|
|
US5298262A
(en)
*
|
1992-12-04 |
1994-03-29 |
Sterling Winthrop Inc. |
Use of ionic cloud point modifiers to prevent particle aggregation during sterilization
|
|
US5346702A
(en)
*
|
1992-12-04 |
1994-09-13 |
Sterling Winthrop Inc. |
Use of non-ionic cloud point modifiers to minimize nanoparticle aggregation during sterilization
|
|
FR2698871B1
(fr)
|
1992-12-09 |
1995-02-24 |
Rhone Poulenc Rorer Sa |
Nouveau taxoïdes, leur préparation et les compositions pharmaceutiques qui les contiennent.
|
|
US6663881B2
(en)
|
1993-01-28 |
2003-12-16 |
Neorx Corporation |
Therapeutic inhibitor of vascular smooth muscle cells
|
|
US5981568A
(en)
|
1993-01-28 |
1999-11-09 |
Neorx Corporation |
Therapeutic inhibitor of vascular smooth muscle cells
|
|
US6491938B2
(en)
|
1993-05-13 |
2002-12-10 |
Neorx Corporation |
Therapeutic inhibitor of vascular smooth muscle cells
|
|
US5525559A
(en)
*
|
1993-02-13 |
1996-06-11 |
Tioxide Specialties Limited |
Preparation of mixed powders
|
|
US20030133955A1
(en)
*
|
1993-02-22 |
2003-07-17 |
American Bioscience, Inc. |
Methods and compositions useful for administration of chemotherapeutic agents
|
|
US5439686A
(en)
*
|
1993-02-22 |
1995-08-08 |
Vivorx Pharmaceuticals, Inc. |
Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor
|
|
US6753006B1
(en)
*
|
1993-02-22 |
2004-06-22 |
American Bioscience, Inc. |
Paclitaxel-containing formulations
|
|
US20070117862A1
(en)
*
|
1993-02-22 |
2007-05-24 |
Desai Neil P |
Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
|
US20030068362A1
(en)
*
|
1993-02-22 |
2003-04-10 |
American Bioscience, Inc. |
Methods and formulations for the delivery of pharmacologically active agents
|
|
US6749868B1
(en)
|
1993-02-22 |
2004-06-15 |
American Bioscience, Inc. |
Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
|
|
US6537579B1
(en)
|
1993-02-22 |
2003-03-25 |
American Bioscience, Inc. |
Compositions and methods for administration of pharmacologically active compounds
|
|
US6096331A
(en)
|
1993-02-22 |
2000-08-01 |
Vivorx Pharmaceuticals, Inc. |
Methods and compositions useful for administration of chemotherapeutic agents
|
|
US6228879B1
(en)
|
1997-10-16 |
2001-05-08 |
The Children's Medical Center |
Methods and compositions for inhibition of angiogenesis
|
|
US8143283B1
(en)
*
|
1993-03-01 |
2012-03-27 |
The Children's Medical Center Corporation |
Methods for treating blood-born tumors with thalidomide
|
|
US6114355A
(en)
*
|
1993-03-01 |
2000-09-05 |
D'amato; Robert |
Methods and compositions for inhibition of angiogenesis
|
|
US5629327A
(en)
*
|
1993-03-01 |
1997-05-13 |
Childrens Hospital Medical Center Corp. |
Methods and compositions for inhibition of angiogenesis
|
|
US5840277A
(en)
*
|
1993-03-30 |
1998-11-24 |
Charlotte Hospital Authority |
Treatment of chronic pulmonary inflammation
|
|
US5830436A
(en)
*
|
1993-03-30 |
1998-11-03 |
Duke University |
Method of mucociliary clearance in cystic fibrosis patients using alkylaryl polyether alcohol polymers
|
|
US5849263A
(en)
*
|
1993-03-30 |
1998-12-15 |
Charlotte-Mecklenburg Hospital Authority |
Pharmaceutical compositions containing alkylaryl polyether alcohol polymer
|
|
CH686761A5
(de)
|
1993-05-27 |
1996-06-28 |
Sandoz Ag |
Galenische Formulierungen.
|
|
US6441026B1
(en)
|
1993-11-08 |
2002-08-27 |
Aventis Pharma S.A. |
Antitumor compositions containing taxane derivatives
|
|
US5534270A
(en)
*
|
1995-02-09 |
1996-07-09 |
Nanosystems Llc |
Method of preparing stable drug nanoparticles
|
|
US5573783A
(en)
*
|
1995-02-13 |
1996-11-12 |
Nano Systems L.L.C. |
Redispersible nanoparticulate film matrices with protective overcoats
|
|
US5510118A
(en)
*
|
1995-02-14 |
1996-04-23 |
Nanosystems Llc |
Process for preparing therapeutic compositions containing nanoparticles
|
|
EP0810853B1
(en)
*
|
1995-02-24 |
2004-08-25 |
Elan Pharma International Limited |
Aerosols containing nanoparticle dispersions
|
|
DE19512484A1
(de)
*
|
1995-04-04 |
1996-10-17 |
Bayer Ag |
Kohlenhydratmodifizierte Cytostatika
|
|
US5731325A
(en)
*
|
1995-06-06 |
1998-03-24 |
Andrulis Pharmaceuticals Corp. |
Treatment of melanomas with thalidomide alone or in combination with other anti-melanoma agents
|
|
US6413536B1
(en)
|
1995-06-07 |
2002-07-02 |
Southern Biosystems, Inc. |
High viscosity liquid controlled delivery system and medical or surgical device
|
|
US7833543B2
(en)
*
|
1995-06-07 |
2010-11-16 |
Durect Corporation |
High viscosity liquid controlled delivery system and medical or surgical device
|
|
WO1997004756A2
(en)
*
|
1995-07-26 |
1997-02-13 |
Nanosystems L.L.C. |
Methacrylate backbone surfactants in nanoparticulate formulations
|
|
US6391338B1
(en)
|
1995-09-07 |
2002-05-21 |
Biovail Technologies Ltd. |
System for rendering substantially non-dissoluble bio-affecting agents bio-available
|
|
US5834025A
(en)
*
|
1995-09-29 |
1998-11-10 |
Nanosystems L.L.C. |
Reduction of intravenously administered nanoparticulate-formulation-induced adverse physiological reactions
|
|
US6346510B1
(en)
*
|
1995-10-23 |
2002-02-12 |
The Children's Medical Center Corporation |
Therapeutic antiangiogenic endostatin compositions
|
|
US5955509A
(en)
*
|
1996-05-01 |
1999-09-21 |
Board Of Regents, The University Of Texas System |
pH dependent polymer micelles
|
|
WO1997045105A1
(en)
*
|
1996-05-24 |
1997-12-04 |
Angiotech Pharmaceuticals, Inc. |
Compositions and methods for treating or preventing diseases of body passageways
|
|
US20030195847A1
(en)
*
|
1996-06-05 |
2003-10-16 |
David Felger |
Method of billing a purchase made over a computer network
|
|
EP0907666A1
(en)
|
1996-06-27 |
1999-04-14 |
G.D. Searle & Co. |
Particles comprising amphiphilic copolymers, having a cross-linked shell domain and an interior core domain, useful for pharmaceutical and other applications
|
|
US6465016B2
(en)
|
1996-08-22 |
2002-10-15 |
Research Triangle Pharmaceuticals |
Cyclosporiine particles
|
|
US7255877B2
(en)
*
|
1996-08-22 |
2007-08-14 |
Jagotec Ag |
Fenofibrate microparticles
|
|
US8137684B2
(en)
*
|
1996-10-01 |
2012-03-20 |
Abraxis Bioscience, Llc |
Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
|
EP1586322B1
(en)
*
|
1996-11-05 |
2008-08-20 |
The Children's Medical Center Corporation |
Compositions comprising thalodimide and dexamethasone for the treatment of cancer& x9;
|
|
US6515016B2
(en)
|
1996-12-02 |
2003-02-04 |
Angiotech Pharmaceuticals, Inc. |
Composition and methods of paclitaxel for treating psoriasis
|
|
FR2759293B1
(fr)
*
|
1997-02-11 |
1999-04-30 |
Ethypharm Lab Prod Ethiques |
Microgranules contenant du cisplatine, procede de fabrication, preparation pharmaceutique et utilisation en polychimiotherapie ou en association avec une radiotherapie
|
|
US6045829A
(en)
*
|
1997-02-13 |
2000-04-04 |
Elan Pharma International Limited |
Nanocrystalline formulations of human immunodeficiency virus (HIV) protease inhibitors using cellulosic surface stabilizers
|
|
WO1998035666A1
(en)
*
|
1997-02-13 |
1998-08-20 |
Nanosystems Llc |
Formulations of nanoparticle naproxen tablets
|
|
WO1998039009A1
(en)
*
|
1997-03-07 |
1998-09-11 |
Sanofi Pharmaceuticals, Inc. |
Method of treating a tumor
|
|
US20050004049A1
(en)
*
|
1997-03-11 |
2005-01-06 |
Elan Pharma International Limited |
Novel griseofulvin compositions
|
|
WO1998047499A1
(en)
*
|
1997-04-22 |
1998-10-29 |
Nippon Kayaku Kabushiki Kaisha |
Flutamide preparations and method for manufacturing the same
|
|
US20020039594A1
(en)
*
|
1997-05-13 |
2002-04-04 |
Evan C. Unger |
Solid porous matrices and methods of making and using the same
|
|
US6051558A
(en)
*
|
1997-05-28 |
2000-04-18 |
Southern Biosystems, Inc. |
Compositions suitable for controlled release of the hormone GnRH and its analogs
|
|
US20060025328A1
(en)
*
|
1997-05-28 |
2006-02-02 |
Burns Patrick J |
Compositions suitable for controlled release of the hormone GnRH and its analogs
|
|
US8853260B2
(en)
*
|
1997-06-27 |
2014-10-07 |
Abraxis Bioscience, Llc |
Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
|
KR100904931B1
(ko)
*
|
1997-06-27 |
2009-06-29 |
아브락시스 바이오사이언스, 엘엘씨 |
나노 입자 및 그의 제조 방법
|
|
US20030199425A1
(en)
*
|
1997-06-27 |
2003-10-23 |
Desai Neil P. |
Compositions and methods for treatment of hyperplasia
|
|
UA72189C2
(ru)
|
1997-11-17 |
2005-02-15 |
Янссен Фармацевтика Н.В. |
Водные суспензии субмикронной формы эфиров 9-гидроксирисперидона жирных кислот
|
|
US20020147143A1
(en)
|
1998-03-18 |
2002-10-10 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of lung cancer
|
|
US6979456B1
(en)
|
1998-04-01 |
2005-12-27 |
Jagotec Ag |
Anticancer compositions
|
|
US6673828B1
(en)
*
|
1998-05-11 |
2004-01-06 |
Children's Medical Center Corporation |
Analogs of 2-Phthalimidinoglutaric acid
|
|
ES2216517T3
(es)
|
1998-05-29 |
2004-10-16 |
Skyepharma Canada Inc. |
Composiciones de microcapsulas termoprotegidas y procedimiento para su esterilizacion terminal con vapor.
|
|
US6153225A
(en)
*
|
1998-08-13 |
2000-11-28 |
Elan Pharma International Limited |
Injectable formulations of nanoparticulate naproxen
|
|
EP1105096B1
(en)
|
1998-08-19 |
2003-10-29 |
Skyepharma Canada Inc. |
Injectable aqueous dispersions of propofol
|
|
US6350786B1
(en)
|
1998-09-22 |
2002-02-26 |
Hoffmann-La Roche Inc. |
Stable complexes of poorly soluble compounds in ionic polymers
|
|
US20030235557A1
(en)
|
1998-09-30 |
2003-12-25 |
Corixa Corporation |
Compositions and methods for WT1 specific immunotherapy
|
|
US8236352B2
(en)
*
|
1998-10-01 |
2012-08-07 |
Alkermes Pharma Ireland Limited |
Glipizide compositions
|
|
US8293277B2
(en)
*
|
1998-10-01 |
2012-10-23 |
Alkermes Pharma Ireland Limited |
Controlled-release nanoparticulate compositions
|
|
EP2266542A3
(en)
*
|
1998-10-01 |
2013-07-31 |
Elan Pharma International Limited |
Controlled release nanoparticulate compositions
|
|
US20040013613A1
(en)
*
|
2001-05-18 |
2004-01-22 |
Jain Rajeev A |
Rapidly disintegrating solid oral dosage form
|
|
US20080213378A1
(en)
*
|
1998-10-01 |
2008-09-04 |
Elan Pharma International, Ltd. |
Nanoparticulate statin formulations and novel statin combinations
|
|
US20070160675A1
(en)
*
|
1998-11-02 |
2007-07-12 |
Elan Corporation, Plc |
Nanoparticulate and controlled release compositions comprising a cephalosporin
|
|
US20090297602A1
(en)
*
|
1998-11-02 |
2009-12-03 |
Devane John G |
Modified Release Loxoprofen Compositions
|
|
DK1126826T6
(en)
*
|
1998-11-02 |
2019-06-24 |
Alkermes Pharma Ireland Ltd |
Multiparticulate modified release of methylphenidate
|
|
US6428814B1
(en)
*
|
1999-10-08 |
2002-08-06 |
Elan Pharma International Ltd. |
Bioadhesive nanoparticulate compositions having cationic surface stabilizers
|
|
US20040141925A1
(en)
*
|
1998-11-12 |
2004-07-22 |
Elan Pharma International Ltd. |
Novel triamcinolone compositions
|
|
US6969529B2
(en)
*
|
2000-09-21 |
2005-11-29 |
Elan Pharma International Ltd. |
Nanoparticulate compositions comprising copolymers of vinyl pyrrolidone and vinyl acetate as surface stabilizers
|
|
US6375986B1
(en)
|
2000-09-21 |
2002-04-23 |
Elan Pharma International Ltd. |
Solid dose nanoparticulate compositions comprising a synergistic combination of a polymeric surface stabilizer and dioctyl sodium sulfosuccinate
|
|
US7521068B2
(en)
*
|
1998-11-12 |
2009-04-21 |
Elan Pharma International Ltd. |
Dry powder aerosols of nanoparticulate drugs
|
|
US6984404B1
(en)
|
1998-11-18 |
2006-01-10 |
University Of Florida Research Foundation, Inc. |
Methods for preparing coated drug particles and pharmaceutical formulations thereof
|
|
IL143197A0
(en)
|
1998-11-20 |
2002-04-21 |
Rtp Pharma Inc |
Dispersible phospholipid stabilized microparticles
|
|
DE69942782D1
(de)
|
1998-11-27 |
2010-10-28 |
Ucb Sa |
Zusammensetzungen und Verfahren zur Erhöhung der Knochenmineralisierung
|
|
US20040009535A1
(en)
|
1998-11-27 |
2004-01-15 |
Celltech R&D, Inc. |
Compositions and methods for increasing bone mineralization
|
|
DE19856432A1
(de)
|
1998-12-08 |
2000-06-15 |
Basf Ag |
Nanopartikuläre Kern-Schale Systeme sowie deren Verwendung in pharmazeutischen und kosmetischen Zubereitungen
|
|
US6040330A
(en)
*
|
1999-01-08 |
2000-03-21 |
Bionumerik Pharmaceuticals, Inc. |
Pharmaceutical formulations of taxanes
|
|
US6267989B1
(en)
|
1999-03-08 |
2001-07-31 |
Klan Pharma International Ltd. |
Methods for preventing crystal growth and particle aggregation in nanoparticulate compositions
|
|
EP1754488A1
(en)
|
1999-05-24 |
2007-02-21 |
Introgen Therapeutics, Inc. |
Methods and compositions for non-viral gene therapy for treatment of hyperproliferative diseases
|
|
US6444223B1
(en)
*
|
1999-05-28 |
2002-09-03 |
Alkermes Controlled Therapeutics, Inc. |
Method of producing submicron particles of a labile agent and use thereof
|
|
US6406745B1
(en)
*
|
1999-06-07 |
2002-06-18 |
Nanosphere, Inc. |
Methods for coating particles and particles produced thereby
|
|
US20040115134A1
(en)
*
|
1999-06-22 |
2004-06-17 |
Elan Pharma International Ltd. |
Novel nifedipine compositions
|
|
US20090104273A1
(en)
*
|
1999-06-22 |
2009-04-23 |
Elan Pharma International Ltd. |
Novel nifedipine compositions
|
|
US6656504B1
(en)
|
1999-09-09 |
2003-12-02 |
Elan Pharma International Ltd. |
Nanoparticulate compositions comprising amorphous cyclosporine and methods of making and using such compositions
|
|
DE60020382T2
(de)
*
|
1999-09-21 |
2006-01-26 |
Skyepharma Canada Inc., Verdun |
Oberflächenmodifizierte teilchenförmige zusammensetzungen biologisch aktiver stoffe
|
|
HK1049787B
(en)
|
1999-10-01 |
2014-07-25 |
Immunogen, Inc. |
Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
|
|
US20040009229A1
(en)
*
|
2000-01-05 |
2004-01-15 |
Unger Evan Charles |
Stabilized nanoparticle formulations of camptotheca derivatives
|
|
AU2001233174A1
(en)
*
|
2000-01-31 |
2001-08-07 |
Engelhard Corporation |
Surfactant free topical compositions and method for rapid preparation thereof
|
|
GB0002952D0
(en)
*
|
2000-02-09 |
2000-03-29 |
Pharma Mar Sa |
Process for producing kahalalide F compounds
|
|
DE60143425D1
(de)
|
2000-02-23 |
2010-12-23 |
Smithkline Beecham Biolog |
Neue verbindungen
|
|
US20040002068A1
(en)
|
2000-03-01 |
2004-01-01 |
Corixa Corporation |
Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
|
|
US20040156872A1
(en)
*
|
2000-05-18 |
2004-08-12 |
Elan Pharma International Ltd. |
Novel nimesulide compositions
|
|
US6316029B1
(en)
|
2000-05-18 |
2001-11-13 |
Flak Pharma International, Ltd. |
Rapidly disintegrating solid oral dosage form
|
|
US10293056B1
(en)
|
2000-05-24 |
2019-05-21 |
Board Of Regents, The University Of Texas System |
Methods and compositions for non-viral gene therapy for treatment of hyperproliferative diseases
|
|
DE60139963D1
(de)
|
2000-06-20 |
2009-10-29 |
Corixa Corp |
Fusionsproteine aus mycobakterium tuberculosis
|
|
EP1961819A3
(en)
|
2000-06-28 |
2008-11-12 |
Corixa Corporation |
Composition and methods for the therapy and diagnosis of lung cancer
|
|
US20080241070A1
(en)
*
|
2000-09-21 |
2008-10-02 |
Elan Pharma International Ltd. |
Fenofibrate dosage forms
|
|
US7198795B2
(en)
*
|
2000-09-21 |
2007-04-03 |
Elan Pharma International Ltd. |
In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate of nanoparticulate active agent compositions
|
|
US7276249B2
(en)
*
|
2002-05-24 |
2007-10-02 |
Elan Pharma International, Ltd. |
Nanoparticulate fibrate formulations
|
|
US20030224058A1
(en)
*
|
2002-05-24 |
2003-12-04 |
Elan Pharma International, Ltd. |
Nanoparticulate fibrate formulations
|
|
US7998507B2
(en)
*
|
2000-09-21 |
2011-08-16 |
Elan Pharma International Ltd. |
Nanoparticulate compositions of mitogen-activated protein (MAP) kinase inhibitors
|
|
RU2179170C1
(ru)
*
|
2000-10-05 |
2002-02-10 |
Жукова Инна Борисовна |
Средство, ингибирующее пролиферацию лимфоцитов
|
|
BR0114713A
(pt)
*
|
2000-10-16 |
2004-01-13 |
Neopharm Inc |
Formulação lipossÈmica de mitoxantrona
|
|
RU2191006C2
(ru)
*
|
2000-10-27 |
2002-10-20 |
Российский онкологический научный центр им. Н.Н.Блохина РАМН |
Способ лечения диссеминированной формы остеогенной саркомы
|
|
CA2430669C
(en)
*
|
2000-11-30 |
2011-06-14 |
The Children's Medical Center Corporation |
Synthesis of 3-amino-thalidomide and its enantiomers
|
|
JP2005500247A
(ja)
*
|
2000-12-07 |
2005-01-06 |
ボード オブ リージェンツ， ザ ユニバーシティ オブ テキサス システム |
ヒトｍｄａ−７に関わる処置方法
|
|
US6977085B2
(en)
*
|
2000-12-22 |
2005-12-20 |
Baxter International Inc. |
Method for preparing submicron suspensions with polymorph control
|
|
US9700866B2
(en)
*
|
2000-12-22 |
2017-07-11 |
Baxter International Inc. |
Surfactant systems for delivery of organic compounds
|
|
US20050048126A1
(en)
*
|
2000-12-22 |
2005-03-03 |
Barrett Rabinow |
Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug
|
|
US8067032B2
(en)
*
|
2000-12-22 |
2011-11-29 |
Baxter International Inc. |
Method for preparing submicron particles of antineoplastic agents
|
|
US6623761B2
(en)
|
2000-12-22 |
2003-09-23 |
Hassan Emadeldin M. |
Method of making nanoparticles of substantially water insoluble materials
|
|
US6951656B2
(en)
*
|
2000-12-22 |
2005-10-04 |
Baxter International Inc. |
Microprecipitation method for preparing submicron suspensions
|
|
US20030072807A1
(en)
*
|
2000-12-22 |
2003-04-17 |
Wong Joseph Chung-Tak |
Solid particulate antifungal compositions for pharmaceutical use
|
|
US20030096013A1
(en)
*
|
2000-12-22 |
2003-05-22 |
Jane Werling |
Preparation of submicron sized particles with polymorph control
|
|
US7193084B2
(en)
*
|
2000-12-22 |
2007-03-20 |
Baxter International Inc. |
Polymorphic form of itraconazole
|
|
US6884436B2
(en)
*
|
2000-12-22 |
2005-04-26 |
Baxter International Inc. |
Method for preparing submicron particle suspensions
|
|
US20040022862A1
(en)
*
|
2000-12-22 |
2004-02-05 |
Kipp James E. |
Method for preparing small particles
|
|
US7037528B2
(en)
*
|
2000-12-22 |
2006-05-02 |
Baxter International Inc. |
Microprecipitation method for preparing submicron suspensions
|
|
US20040256749A1
(en)
*
|
2000-12-22 |
2004-12-23 |
Mahesh Chaubal |
Process for production of essentially solvent-free small particles
|
|
JP4711600B2
(ja)
|
2001-01-26 |
2011-06-29 |
シェーリング コーポレイション |
シトステロール血症の処置のための置換アゼチジノン化合物の使用
|
|
SI1413331T1
(sl)
|
2001-01-26 |
2008-02-29 |
Schering Corp |
Kombinacije fenofibrata peroksisomskega proliferator aktivirajocega receptorja (PPAR) z ezetimib zaviralcem absorpcije sterola za vaskularne indikacije
|
|
US20060287254A1
(en)
*
|
2001-01-26 |
2006-12-21 |
Schering Corporation |
Use of substituted azetidinone compounds for the treatment of sitosterolemia
|
|
US7071181B2
(en)
|
2001-01-26 |
2006-07-04 |
Schering Corporation |
Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors
|
|
US20020150615A1
(en)
*
|
2001-02-12 |
2002-10-17 |
Howard Sands |
Injectable pharmaceutical composition comprising microdroplets of a camptothecin
|
|
US6497896B2
(en)
|
2001-02-12 |
2002-12-24 |
Supergen, Inc. |
Method for administering camptothecins via injection of a pharmaceutical composition comprising microdroplets containing a camptothecin
|
|
US6509027B2
(en)
|
2001-02-12 |
2003-01-21 |
Supergen, Inc. |
Injectable pharmaceutical composition comprising coated particles of camptothecin
|
|
BR0208626A
(pt)
|
2001-04-03 |
2004-03-09 |
Schering Corp |
Composição antifúngica com biodisponibilidade intensificada
|
|
US6613083B2
(en)
|
2001-05-02 |
2003-09-02 |
Eckhard Alt |
Stent device and method
|
|
EP1515982A4
(en)
|
2001-05-09 |
2005-10-26 |
Corixa Corp |
COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF PROSTATE CANCER
|
|
US6976647B2
(en)
*
|
2001-06-05 |
2005-12-20 |
Elan Pharma International, Limited |
System and method for milling materials
|
|
US20030087308A1
(en)
*
|
2001-06-22 |
2003-05-08 |
Elan Pharma International Limited |
Method for high through put screening using a small scale mill or microfluidics
|
|
US20030054042A1
(en)
*
|
2001-09-14 |
2003-03-20 |
Elaine Liversidge |
Stabilization of chemical compounds using nanoparticulate formulations
|
|
ES2280582T3
(es)
*
|
2001-09-19 |
2007-09-16 |
Elan Pharma International Limited |
Formulaciones de insulina en nanoparticulas.
|
|
US7053080B2
(en)
|
2001-09-21 |
2006-05-30 |
Schering Corporation |
Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
|
|
US7132415B2
(en)
*
|
2001-09-21 |
2006-11-07 |
Schering Corporation |
Methods and therapeutic combinations for the treatment of xanthoma using sterol absorption inhibitors
|
|
CN1558755A
(zh)
*
|
2001-09-26 |
2004-12-29 |
���ع��ʹ�˾ |
通过分散和除去溶剂或液相制备亚微米大小的纳米颗粒
|
|
US20060003012A9
(en)
*
|
2001-09-26 |
2006-01-05 |
Sean Brynjelsen |
Preparation of submicron solid particle suspensions by sonication of multiphase systems
|
|
EP1443912B1
(en)
*
|
2001-10-12 |
2007-08-29 |
Elan Pharma International Limited |
Compositions having a combination of immediate release and controlled release characteristics
|
|
JP2005508354A
(ja)
*
|
2001-10-15 |
2005-03-31 |
クリチテック インコーポレーテッド |
水に溶けにくい薬物の送込み用組成物および方法並びに治療方法
|
|
US7112340B2
(en)
*
|
2001-10-19 |
2006-09-26 |
Baxter International Inc. |
Compositions of and method for preparing stable particles in a frozen aqueous matrix
|
|
WO2003039601A1
(en)
*
|
2001-11-07 |
2003-05-15 |
Imcor Pharmaceutical Company |
Methods for vascular imaging using nanoparticulate contrast agents
|
|
RU2191581C1
(ru)
*
|
2001-11-16 |
2002-10-27 |
Нестерук Владимир Викторович |
Способ получения раствора фторурацила
|
|
WO2003047497A1
(en)
*
|
2001-12-06 |
2003-06-12 |
Ranbaxy Laboratories Limited |
Isotretinoin nanoparticulate compositions
|
|
UA76810C2
(ru)
*
|
2001-12-10 |
2006-09-15 |
Мерк Енд Ко., Інк. |
Фармацевтическая композиция антагониста рецептора тахикинина в форме наночастиц
|
|
CA2860702C
(en)
|
2001-12-17 |
2019-02-26 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of inflammatory bowel disease
|
|
JP2005513145A
(ja)
*
|
2001-12-21 |
2005-05-12 |
セラター テクノロジーズ インコーポレイテッド |
改変されたポリマー脂質送達ビヒクル
|
|
US20030129242A1
(en)
*
|
2002-01-04 |
2003-07-10 |
Bosch H. William |
Sterile filtered nanoparticulate formulations of budesonide and beclomethasone having tyloxapol as a surface stabilizer
|
|
US20040101566A1
(en)
*
|
2002-02-04 |
2004-05-27 |
Elan Pharma International Limited |
Novel benzoyl peroxide compositions
|
|
JP4598399B2
(ja)
*
|
2002-02-04 |
2010-12-15 |
エラン ファーマ インターナショナル，リミティド |
表面安定剤としてリゾチームを有するナノ粒子組成物
|
|
US20030164219A1
(en)
*
|
2002-02-20 |
2003-09-04 |
Joerg Brahm |
Headliner/duct assembly and welding process therefor
|
|
JP2005533000A
(ja)
*
|
2002-03-05 |
2005-11-04 |
ボード オブ リージェンツ， ザ ユニバーシティ オブ テキサス システム |
Ｍｄａ−７に関与する免疫誘導を増強する方法
|
|
EP1800666A1
(en)
*
|
2002-03-20 |
2007-06-27 |
Elan Pharma International Limited |
Nanoparticulate compositions of angiogenesis inhibitors
|
|
ATE343376T1
(de)
*
|
2002-03-20 |
2006-11-15 |
Elan Pharma Int Ltd |
Nanopartikelzusammensetzungen von angiogeneseinhibitoren
|
|
US20080220075A1
(en)
*
|
2002-03-20 |
2008-09-11 |
Elan Pharma International Ltd. |
Nanoparticulate compositions of angiogenesis inhibitors
|
|
JP2005526095A
(ja)
*
|
2002-03-20 |
2005-09-02 |
エラン ファーマ インターナショナル，リミティド |
脆砕性の低い急速溶解投与剤型
|
|
US20040076586A1
(en)
*
|
2002-03-28 |
2004-04-22 |
Reinhard Koening |
Compositions and methods for delivering pharmaceutically active agents using nanoparticulates
|
|
WO2003087763A2
(en)
|
2002-04-03 |
2003-10-23 |
Celltech R & D, Inc. |
Association of polymorphisms in the sost gene region with bone mineral density
|
|
AU2003237798A1
(en)
|
2002-04-05 |
2003-10-27 |
Board Of Regents, The University Of Texas System |
Intrapleural single-chain urokinase alone or complexed to its soluble receptor protects against pleural adhesions
|
|
ATE539737T1
(de)
|
2002-04-12 |
2012-01-15 |
Alkermes Pharma Ireland Ltd |
Nanopartikuläre megestrol- formulierungen
|
|
US20100226989A1
(en)
*
|
2002-04-12 |
2010-09-09 |
Elan Pharma International, Limited |
Nanoparticulate megestrol formulations
|
|
US9101540B2
(en)
|
2002-04-12 |
2015-08-11 |
Alkermes Pharma Ireland Limited |
Nanoparticulate megestrol formulations
|
|
US7101576B2
(en)
*
|
2002-04-12 |
2006-09-05 |
Elan Pharma International Limited |
Nanoparticulate megestrol formulations
|
|
US20040105889A1
(en)
*
|
2002-12-03 |
2004-06-03 |
Elan Pharma International Limited |
Low viscosity liquid dosage forms
|
|
AU2003234452A1
(en)
*
|
2002-05-06 |
2003-11-11 |
Elan Pharma International Ltd. |
Nanoparticulate nystatin formulations
|
|
KR20100110378A
(ko)
*
|
2002-05-24 |
2010-10-12 |
안지오테크 인터내셔날 아게 |
의료용 임플란트를 피복하기 위한 조성물 및 방법
|
|
US20070264348A1
(en)
*
|
2002-05-24 |
2007-11-15 |
Elan Pharma International, Ltd. |
Nanoparticulate fibrate formulations
|
|
US8313760B2
(en)
*
|
2002-05-24 |
2012-11-20 |
Angiotech International Ag |
Compositions and methods for coating medical implants
|
|
KR100530369B1
(ko)
*
|
2002-05-27 |
2005-11-22 |
이영환 |
항암물질에 나노입자를 결합시킨 주사 제형의 약물 시스템
|
|
WO2003103632A1
(en)
*
|
2002-06-10 |
2003-12-18 |
Elan Pharma International, Ltd. |
Nanoparticulate polycosanol formulations and novel polycosanol combinations
|
|
CA2488499C
(en)
*
|
2002-06-10 |
2013-03-19 |
Elan Pharma International Ltd. |
Nanoparticulate formulations comprising hmg coa reductase inhibitor derivatives ("statins"),combinations thereof as well as manufacturing of these pharmaceutical compositions
|
|
US20040001889A1
(en)
|
2002-06-25 |
2004-01-01 |
Guohua Chen |
Short duration depot formulations
|
|
CA2492488A1
(en)
*
|
2002-07-16 |
2004-01-22 |
Elan Pharma International, Ltd. |
Liquid dosage compositions of stable nanoparticulate active agents
|
|
AU2003249474A1
(en)
|
2002-08-12 |
2004-02-25 |
Pfizer Products Inc. |
Pharmaceutical compositions of semi-ordered drugs and polymers
|
|
EP2269618A1
(en)
|
2002-08-12 |
2011-01-05 |
Jennerex Biotherapeutics ULC |
An oncolytic vaccinia virus for use in combination with a chemotherapy for treating cancer.
|
|
ES2355723T3
(es)
*
|
2002-09-11 |
2011-03-30 |
Elan Pharma International Limited |
Composiciones de agente activo en nanopartículas estabilizadas en gel.
|
|
WO2004032980A1
(en)
*
|
2002-10-04 |
2004-04-22 |
Elan Pharma International Limited |
Gamma irradiation of solid nanoparticulate active agents
|
|
US6966990B2
(en)
|
2002-10-11 |
2005-11-22 |
Ferro Corporation |
Composite particles and method for preparing
|
|
GB0304367D0
(en)
*
|
2003-02-26 |
2003-04-02 |
Pharma Mar Sau |
Methods for treating psoriasis
|
|
CA2504878A1
(en)
|
2002-11-06 |
2004-05-27 |
Schering Corporation |
Cholesterol absorption inhibitors for the treatment of demyelination
|
|
ATE514418T1
(de)
*
|
2002-11-12 |
2011-07-15 |
Elan Pharma Int Ltd |
Rasch zerfallende feste darreichungsformen mit nichtbröseliger konsistenz und pullulan
|
|
EP1935407A1
(en)
*
|
2002-12-03 |
2008-06-25 |
Elan Pharma International Limited |
Low viscosity liquid dosage forms
|
|
LT1585548T
(lt)
*
|
2002-12-09 |
2018-09-25 |
Abraxis Bioscience, Llc |
Farmakologinių agentų kompozicijos ir įvedimo būdai
|
|
SI1575569T1
(sl)
|
2002-12-13 |
2010-12-31 |
Durect Corp |
Oralni sistem dostave zdravila, ki obsega visokoviskozne tekoče nosilne materiale
|
|
US20040173696A1
(en)
*
|
2002-12-17 |
2004-09-09 |
Elan Pharma International Ltd. |
Milling microgram quantities of nanoparticulate candidate compounds
|
|
ES2556970T3
(es)
|
2003-01-06 |
2016-01-21 |
Corixa Corporation |
Ciertos compuestos de fosfato de aminoalquil glucosaminida y sus usos
|
|
US7960522B2
(en)
|
2003-01-06 |
2011-06-14 |
Corixa Corporation |
Certain aminoalkyl glucosaminide phosphate compounds and their use
|
|
CA2513064C
(en)
*
|
2003-01-31 |
2009-11-10 |
Elan Pharma International, Ltd. |
Nanoparticulate topiramate formulations
|
|
US20040208833A1
(en)
*
|
2003-02-04 |
2004-10-21 |
Elan Pharma International Ltd. |
Novel fluticasone formulations
|
|
US7083748B2
(en)
*
|
2003-02-07 |
2006-08-01 |
Ferro Corporation |
Method and apparatus for continuous particle production using supercritical fluid
|
|
US6931888B2
(en)
|
2003-02-07 |
2005-08-23 |
Ferro Corporation |
Lyophilization method and apparatus for producing particles
|
|
BRPI0408063A
(pt)
*
|
2003-03-03 |
2006-02-14 |
Univ Texas |
métodos e composições envolvendo mda-7
|
|
US8512727B2
(en)
*
|
2003-03-03 |
2013-08-20 |
Alkermes Pharma Ireland Limited |
Nanoparticulate meloxicam formulations
|
|
US20100297252A1
(en)
*
|
2003-03-03 |
2010-11-25 |
Elan Pharma International Ltd. |
Nanoparticulate meloxicam formulations
|
|
CN1756755A
(zh)
|
2003-03-07 |
2006-04-05 |
先灵公司 |
取代的2－吖丁啶酮化合物、其制剂及其治疗高胆甾醇血症的用途
|
|
JP4589919B2
(ja)
*
|
2003-03-07 |
2010-12-01 |
シェーリング コーポレイション |
高コレステロール血症の処置のための、置換アゼチジノン化合物、これらの処方物および使用
|
|
US7459442B2
(en)
*
|
2003-03-07 |
2008-12-02 |
Schering Corporation |
Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
|
|
CN100439361C
(zh)
|
2003-03-07 |
2008-12-03 |
先灵公司 |
取代的2-吖丁啶酮化合物、其制剂及其治疗高胆甾醇血症的用途
|
|
CA2520475C
(en)
*
|
2003-04-03 |
2012-10-09 |
Jessie L.-S. Au |
Tumor-targeting drug-loaded particles
|
|
US20060008531A1
(en)
*
|
2003-05-08 |
2006-01-12 |
Ferro Corporation |
Method for producing solid-lipid composite drug particles
|
|
DE10323597A1
(de)
*
|
2003-05-19 |
2004-12-09 |
Aesculap Ag & Co. Kg |
Medizintechnisches Produkt, Verfahren zu seiner Herstellung und Verwendung
|
|
WO2004103346A1
(en)
*
|
2003-05-20 |
2004-12-02 |
Ranbaxy Laboratories Limited |
Pharmaceutical compositions of acitretin
|
|
CA2523035C
(en)
*
|
2003-05-22 |
2011-04-26 |
Elan Pharma International Ltd. |
Sterilization of dispersions of nanoparticulate active agents with gamma radiation
|
|
EP1636270B1
(en)
|
2003-06-16 |
2016-07-20 |
UCB Pharma S.A. |
Antibodies specific for sclerostin and methods for increasing bone mineralization
|
|
US20050106310A1
(en)
*
|
2003-07-02 |
2005-05-19 |
Green John H. |
Designed particle agglomeration
|
|
CN101291653B
(zh)
|
2003-07-16 |
2012-06-27 |
普洛体维生物治疗公司 |
脂质包封的干扰rna
|
|
ES2318330T3
(es)
*
|
2003-08-08 |
2009-05-01 |
Elan Pharma International Limited |
Nuevas composiciones de metaxalona.
|
|
US7419996B2
(en)
*
|
2003-08-13 |
2008-09-02 |
The University Of Houston |
Parenteral and oral formulations of benzimidazoles
|
|
GB0327723D0
(en)
*
|
2003-09-15 |
2003-12-31 |
Vectura Ltd |
Pharmaceutical compositions
|
|
AU2004285468B2
(en)
|
2003-10-22 |
2011-02-24 |
Fred Hutchinson Cancer Research Center |
Methods, compositions and devices for inducing stasis in cells, tissues, organs, and organisms
|
|
CA2544627A1
(en)
*
|
2003-11-05 |
2005-05-19 |
Elan Pharma International Ltd. |
Nanoparticulate compositions having a peptide as a surface stabilizer
|
|
EP1687041A2
(en)
*
|
2003-11-20 |
2006-08-09 |
Angiotech International AG |
Soft tissue implants and anti-scarring agents
|
|
EP1688169A4
(en)
*
|
2003-11-28 |
2008-10-01 |
Mitsubishi Chem Corp |
PROCESS FOR PRODUCING FINE PARTICLES OF AN ORGANIC COMPOUND
|
|
WO2005082396A2
(en)
*
|
2003-12-01 |
2005-09-09 |
Introgen Therapeutics, Inc. |
Use of mda-7 to inhibit infection by pathogenic organisms
|
|
US20070281041A1
(en)
*
|
2004-03-02 |
2007-12-06 |
Introgen Therapeutics, Inc. |
Compositions and Methods Involving MDA-7 for the Treatment of Cancer
|
|
DE102004011776A1
(de)
*
|
2004-03-09 |
2005-11-03 |
Lts Lohmann Therapie-Systeme Ag |
Trägersystem in Form von Nanopartikeln auf Proteinbasis zur zellspezifischen Anreicherung von pharmazeutisch aktiven Wirkstoffen
|
|
EP1730516A1
(en)
*
|
2004-03-30 |
2006-12-13 |
Pfizer Products Incorporated |
Method and device for evaluation of pharmaceutical compositions
|
|
US20050220866A1
(en)
*
|
2004-04-02 |
2005-10-06 |
Dr. Reddy's Laboratories Limited |
Novel capsule formulations of etoposide for oral use
|
|
ES2246694B1
(es)
*
|
2004-04-29 |
2007-05-01 |
Instituto Cientifico Y Tecnologico De Navarra, S.A. |
Nanoparticulas pegiladas.
|
|
CA2837748C
(en)
|
2004-05-25 |
2016-03-08 |
Oregon Health And Science University |
Siv and hiv vaccination using rhcmv-and hcmv-based vaccine vectors
|
|
US7871632B2
(en)
|
2004-07-12 |
2011-01-18 |
Adventrx Pharmaceuticals, Inc. |
Compositions for delivering highly water soluble drugs
|
|
KR20070043894A
(ko)
*
|
2004-08-19 |
2007-04-25 |
알자 코포레이션 |
제어 방출형 나노입자 활성제 제제 제형 및 방법
|
|
WO2006028074A1
(ja)
*
|
2004-09-07 |
2006-03-16 |
Mitsubishi Chemical Corporation |
微粒子化された物質の製造方法および微粒子化された物質
|
|
EP3103477A1
(en)
*
|
2004-09-17 |
2016-12-14 |
Durect Corporation |
Sustained local anesthetic composition containing saib
|
|
CA2580606A1
(en)
|
2004-09-18 |
2006-03-30 |
University Of Maryland, Baltimore |
Therapeutic agents targeting the ncca-atp channel and methods of use thereof
|
|
CN101043891A
(zh)
|
2004-09-18 |
2007-09-26 |
巴尔的摩马里兰大学 |
靶向NCCa－ATP通道的治疗剂及其使用方法
|
|
US20090155331A1
(en)
*
|
2005-11-16 |
2009-06-18 |
Elan Pharma International Limited |
Injectable nanoparticulate olanzapine formulations
|
|
US7910577B2
(en)
*
|
2004-11-16 |
2011-03-22 |
Elan Pharma International Limited |
Injectable nanoparticulate olanzapine formulations
|
|
UA89513C2
(ru)
*
|
2004-12-03 |
2010-02-10 |
Элан Фарма Интернешнл Лтд. |
Стабильная композиция из наночастичек ралоксифена гидрохлорида
|
|
SG161203A1
(en)
*
|
2004-12-15 |
2010-05-27 |
Elan Pharma Int Ltd |
Nanoparticulate tacrolimus formulations
|
|
US20060159767A1
(en)
*
|
2004-12-22 |
2006-07-20 |
Elan Pharma International Limited |
Nanoparticulate bicalutamide formulations
|
|
CA2594332A1
(en)
*
|
2005-01-06 |
2006-07-13 |
Elan Pharma International Ltd. |
Nanoparticulate candesartan formulations
|
|
AU2006211960A1
(en)
*
|
2005-02-08 |
2006-08-17 |
Board Of Regents, The University Of Texas System |
Compositions and methods involving MDA-7 for the treatment of cancer
|
|
EA013433B1
(ru)
*
|
2005-02-15 |
2010-04-30 |
Элан Фарма Интернэшнл Лтд. |
Аэрозольные и впрыскиваемые рецептуры лекарственных препаратов бензодиазепина, состоящего из наночастиц
|
|
NZ595313A
(en)
|
2005-02-18 |
2013-03-28 |
Abraxis Bioscience Llc |
The Use Of Nanoparticles Comprising Rapamycin Or Taxane In The Treatment Of Proliferative Diseases
|
|
US8735394B2
(en)
|
2005-02-18 |
2014-05-27 |
Abraxis Bioscience, Llc |
Combinations and modes of administration of therapeutic agents and combination therapy
|
|
BRPI0608173A2
(pt)
*
|
2005-02-24 |
2010-11-09 |
Elan Pharma Int Ltd |
composição, uso da mesma, e, método de produzir uma composição de docetaxel nanoparticulada ou análogo do mesmo
|
|
AU2005100176A4
(en)
*
|
2005-03-01 |
2005-04-07 |
Gym Tv Pty Ltd |
Garbage bin clip
|
|
US20080254114A1
(en)
*
|
2005-03-03 |
2008-10-16 |
Elan Corporation Plc |
Controlled Release Compositions Comprising Heterocyclic Amide Derivative Nanoparticles
|
|
US20060204588A1
(en)
*
|
2005-03-10 |
2006-09-14 |
Elan Pharma International Limited |
Formulations of a nanoparticulate finasteride, dutasteride or tamsulosin hydrochloride, and mixtures thereof
|
|
US20070065374A1
(en)
*
|
2005-03-16 |
2007-03-22 |
Elan Pharma International Limited |
Nanoparticulate leukotriene receptor antagonist/corticosteroid formulations
|
|
WO2006101972A2
(en)
*
|
2005-03-17 |
2006-09-28 |
Elan Pharma International Limited |
Injectable compositions of nanoparticulate immunosuppressive compounds
|
|
EA200701997A1
(ru)
*
|
2005-03-17 |
2008-02-28 |
Элан Фарма Интернэшнл Лтд. |
Композиция из наночастиц бисфосфоната
|
|
AU2006226887A1
(en)
*
|
2005-03-23 |
2006-09-28 |
Elan Pharma International Limited |
Nanoparticulate corticosteroid and antihistamine formulations
|
|
WO2006104890A2
(en)
|
2005-03-31 |
2006-10-05 |
Glaxosmithkline Biologicals Sa |
Vaccines against chlamydial infection
|
|
BRPI0607537A2
(pt)
*
|
2005-04-12 |
2009-09-15 |
Elan Pharma Int Ltd |
formulações de derivado de quinazolina nanoparticulado
|
|
WO2006110802A1
(en)
*
|
2005-04-12 |
2006-10-19 |
Elan Pharma International Limited |
Nanoparticulate and controlled release compositions comprising cyclosporine
|
|
US20060246141A1
(en)
*
|
2005-04-12 |
2006-11-02 |
Elan Pharma International, Limited |
Nanoparticulate lipase inhibitor formulations
|
|
CA2605652C
(en)
|
2005-04-22 |
2016-05-24 |
Universite De Geneve |
Polylactide compositions and uses thereof
|
|
ITMI20050739A1
(it)
*
|
2005-04-22 |
2006-10-23 |
Effebi Spa |
Piastrina di connsessione valvola-attuatore
|
|
KR20130110233A
(ko)
|
2005-04-29 |
2013-10-08 |
글락소스미스클라인 바이오로지칼즈 에스.에이. |
결핵균 감염을 예방 또는 치료하기 위한 신규한 방법
|
|
US7592429B2
(en)
|
2005-05-03 |
2009-09-22 |
Ucb Sa |
Sclerostin-binding antibody
|
|
US8003108B2
(en)
|
2005-05-03 |
2011-08-23 |
Amgen Inc. |
Sclerostin epitopes
|
|
US20110064803A1
(en)
*
|
2005-05-10 |
2011-03-17 |
Elan Pharma International Limited. |
Nanoparticulate and controlled release compositions comprising vitamin k2
|
|
JP2008540550A
(ja)
*
|
2005-05-10 |
2008-11-20 |
エラン・ファルマ・インターナショナル・リミテッド |
ビタミンｋ２を含むナノ粒子および制御放出組成物
|
|
US20100028439A1
(en)
*
|
2005-05-23 |
2010-02-04 |
Elan Pharma International Limited |
Nanoparticulate stabilized anti-hypertensive compositions
|
|
US20060292214A1
(en)
*
|
2005-06-03 |
2006-12-28 |
Elan Pharma International Limited |
Nanoparticulate acetaminophen formulations
|
|
CN101232870A
(zh)
*
|
2005-06-03 |
2008-07-30 |
伊兰制药国际有限公司 |
纳米微粒甲磺酸伊马替尼制剂
|
|
WO2006133045A1
(en)
*
|
2005-06-03 |
2006-12-14 |
Elan Pharma International, Limited |
Nanoparticulate benidipine compositions
|
|
EP1954253A4
(en)
|
2005-06-08 |
2011-07-27 |
Elan Pharma Int Ltd |
NANOTEILIC AND CONTROLLED RELEASED COMPOSITIONS WITH CEFDITORS
|
|
EP1898882B1
(en)
*
|
2005-06-09 |
2009-10-28 |
Elan Pharma International Limited |
Nanoparticulate ebastine formulations
|
|
CN101237868A
(zh)
*
|
2005-06-13 |
2008-08-06 |
伊兰制药国际有限公司 |
纳米粒氯吡格雷和阿司匹林组合制剂
|
|
US20060280787A1
(en)
*
|
2005-06-14 |
2006-12-14 |
Baxter International Inc. |
Pharmaceutical formulation of the tubulin inhibitor indibulin for oral administration with improved pharmacokinetic properties, and process for the manufacture thereof
|
|
US20060280786A1
(en)
*
|
2005-06-14 |
2006-12-14 |
Rabinow Barrett E |
Pharmaceutical formulations for minimizing drug-drug interactions
|
|
JP2008543862A
(ja)
*
|
2005-06-15 |
2008-12-04 |
エラン ファーマ インターナショナル リミテッド |
ナノ粒子アゼルニジピン製剤
|
|
AU2006262144A1
(en)
*
|
2005-06-22 |
2007-01-04 |
Elan Pharma International, Limited |
Nanoparticulate megestrol formulations
|
|
CA2614412A1
(en)
*
|
2005-07-07 |
2007-01-18 |
Elan Pharma International, Limited |
Nanoparticulate clarithromycin formulations
|
|
US20070027105A1
(en)
|
2005-07-26 |
2007-02-01 |
Alza Corporation |
Peroxide removal from drug delivery vehicle
|
|
WO2007016597A2
(en)
*
|
2005-07-29 |
2007-02-08 |
The Regents Of The University Of California |
Targeting tnf-alpha converting enzyme (tace)-dependent growth factor shedding in cancer therapy
|
|
GB0516549D0
(en)
*
|
2005-08-12 |
2005-09-21 |
Sulaiman Brian |
Milling system
|
|
EP1933857A2
(en)
*
|
2005-09-07 |
2008-06-25 |
Jennerex Biotherapeutics ULC |
Systemic treatment of metastatic and/or systemically-disseminated cancers using gm-csf-expressing poxviruses
|
|
US8980246B2
(en)
|
2005-09-07 |
2015-03-17 |
Sillajen Biotherapeutics, Inc. |
Oncolytic vaccinia virus cancer therapy
|
|
WO2007033239A2
(en)
*
|
2005-09-13 |
2007-03-22 |
Elan Pharma International, Limited |
Nanoparticulate tadalafil formulations
|
|
EP1933814A2
(en)
|
2005-09-15 |
2008-06-25 |
Elan Pharma International Limited |
Nanoparticulate aripiprazole formulations
|
|
WO2007041079A2
(en)
*
|
2005-09-30 |
2007-04-12 |
Alza Corporation |
Banded controlled release nanoparticle active agent formulation dosage forms and methods
|
|
CA2628630A1
(en)
*
|
2005-11-15 |
2007-05-24 |
Baxter International Inc. |
Compositions of lipoxygenase inhibitors
|
|
US8883841B2
(en)
|
2005-11-23 |
2014-11-11 |
The Board Of Regents Of The University Of Texas System |
Oncogenic ras-specific cytotoxic compound and methods of use thereof
|
|
CN101583620B
(zh)
|
2005-11-28 |
2016-08-17 |
马里纳斯医药公司 |
加奈索酮组合物及其制备和使用方法
|
|
US20070135407A1
(en)
|
2005-11-28 |
2007-06-14 |
Steiner Mitchell S |
Serm reduction of lipid profiles
|
|
EP1979488A4
(en)
|
2006-01-09 |
2009-05-27 |
Univ California |
IMMUNOSTIMULATING COMBINATIONS OF TNFRSF, TLR, NLR, RHR, PURINERIC RECEPTOR, AND CYTOKIN RECEPTOR ANTONISTS FOR VACCINES AND TUMOR IMMUNOTHERAPY
|
|
WO2007092944A2
(en)
*
|
2006-02-08 |
2007-08-16 |
Introgen Therapeutics, Inc. |
Compositions and methods involving gene therapy and proteasome modulation
|
|
US8367112B2
(en)
*
|
2006-02-28 |
2013-02-05 |
Alkermes Pharma Ireland Limited |
Nanoparticulate carverdilol formulations
|
|
US20080166411A1
(en)
*
|
2006-04-10 |
2008-07-10 |
Pfizer Inc |
Injectable Depot Formulations And Methods For Providing Sustained Release Of Poorly Soluble Drugs Comprising Nanoparticles
|
|
MX2008013576A
(es)
*
|
2006-04-24 |
2009-01-07 |
Bruce Medical Ab |
Agentes anticancerigenos a base de polimeros.
|
|
JP4204634B2
(ja)
*
|
2006-05-15 |
2009-01-07 |
株式会社荏原製作所 |
難水溶性医薬
|
|
MX2008015275A
(es)
*
|
2006-05-30 |
2009-02-06 |
Elan Pharma Int Ltd |
Formulaciones de posaconazol en nanoparticulas.
|
|
US20080213374A1
(en)
*
|
2006-07-10 |
2008-09-04 |
Elan Pharma International Limited |
Nanoparticulate sorafenib formulations
|
|
CL2007002567A1
(es)
|
2006-09-08 |
2008-02-01 |
Amgen Inc |
Proteinas aisladas de enlace a activina a humana.
|
|
US8652782B2
(en)
|
2006-09-12 |
2014-02-18 |
Longhorn Vaccines & Diagnostics, Llc |
Compositions and methods for detecting, identifying and quantitating mycobacterial-specific nucleic acids
|
|
US8080645B2
(en)
*
|
2007-10-01 |
2011-12-20 |
Longhorn Vaccines & Diagnostics Llc |
Biological specimen collection/transport compositions and methods
|
|
US8097419B2
(en)
|
2006-09-12 |
2012-01-17 |
Longhorn Vaccines & Diagnostics Llc |
Compositions and method for rapid, real-time detection of influenza A virus (H1N1) swine 2009
|
|
US9481912B2
(en)
|
2006-09-12 |
2016-11-01 |
Longhorn Vaccines And Diagnostics, Llc |
Compositions and methods for detecting and identifying nucleic acid sequences in biological samples
|
|
CA2921063C
(en)
|
2006-09-15 |
2020-01-28 |
Ottawa Hospital Research Institute |
Oncolytic rhabdovirus
|
|
EP2145001A2
(en)
|
2006-09-19 |
2010-01-20 |
Asuragen, Inc. |
Mir-15, mir-26, mir -31,mir -145, mir-147, mir-188, mir-215, mir-216 mir-331, mmu-mir-292-3p regulated genes and pathways as targets for therapeutic intervention
|
|
CA2699184A1
(en)
*
|
2006-09-22 |
2008-03-27 |
Labopharm Inc. |
Compositions and methods for ph targeted drug delivery
|
|
US8466154B2
(en)
|
2006-10-27 |
2013-06-18 |
The Board Of Regents Of The University Of Texas System |
Methods and compositions related to wrapping of dehydrons
|
|
PL2117521T3
(pl)
|
2006-11-03 |
2012-11-30 |
Durect Corp |
Transdermalne systemy dostarczania zawierające bupiwakainę
|
|
US20100036091A1
(en)
*
|
2006-11-10 |
2010-02-11 |
Amgen Inc. |
Antibody-based diagnostics and therapeutics
|
|
WO2008133722A2
(en)
*
|
2006-11-10 |
2008-11-06 |
Ucb Pharma S.A. |
Anti human sclerostin antibodies
|
|
EP2097092A4
(en)
|
2006-11-21 |
2010-04-07 |
|
MODULATION OF RHAMM (CD168) FOR THE SELECTIVE DEVELOPMENT OF ADIPOSIS TISSUE
|
|
AU2007325628A1
(en)
|
2006-11-28 |
2008-06-05 |
Marinus Pharmaceuticals |
Nanoparticulate formulations and methods for the making and use thereof
|
|
US20100062073A1
(en)
*
|
2006-11-29 |
2010-03-11 |
Ronald Arthur Beyerinck |
Pharmaceutical compositions comprising nanoparticles comprising enteric polymers casein
|
|
PE20081506A1
(es)
|
2006-12-12 |
2008-12-09 |
Infinity Discovery Inc |
Formulaciones de ansamicina
|
|
WO2008080047A2
(en)
*
|
2006-12-23 |
2008-07-03 |
Baxter International Inc. |
Magnetic separation of fine particles from compositions
|
|
CA2674949A1
(en)
|
2007-01-12 |
2008-07-24 |
J. Marc Simard |
Targeting ncca-atp channel for organ protection following ischemic episode
|
|
AU2008214095B2
(en)
|
2007-02-02 |
2014-07-10 |
Baylor College Of Medicine |
Compositions and methods for the treatment of metabolic disorders
|
|
WO2008098160A1
(en)
|
2007-02-09 |
2008-08-14 |
University Of Maryland, Baltimore |
Antagonists of a non-selective cation channel in neural cells
|
|
KR20080084528A
(ko)
|
2007-03-15 |
2008-09-19 |
제네렉스 바이오테라퓨틱스 인크. |
종양살상형 백시니아 바이러스 암 치료
|
|
BRPI0809926B8
(pt)
*
|
2007-04-04 |
2021-05-25 |
Infectious Disease Res Inst |
composição que compreende antígenos de mycobacterium tuberculosis, polipeptídeo de fusão isolado, polinucleotídeo isolado que codifica o dito polipeptídeo e uso da dita composição para estimular uma resposta imune protetora
|
|
EP2623605B1
(en)
|
2007-04-09 |
2018-11-28 |
University of Florida Research Foundation, Inc. |
RAAV vector compositions having tyrosine-modified capsid proteins and methods for use
|
|
US9725485B2
(en)
|
2012-05-15 |
2017-08-08 |
University Of Florida Research Foundation, Inc. |
AAV vectors with high transduction efficiency and uses thereof for gene therapy
|
|
WO2008125940A2
(en)
*
|
2007-04-17 |
2008-10-23 |
Pfizer Products Inc. |
Nanoparticles comprising non-crystalline drug
|
|
WO2008135855A2
(en)
*
|
2007-05-03 |
2008-11-13 |
Pfizer Products Inc. |
Nanoparticles comprising a cholesteryl ester transfer protein inhibitor and a nonionizable polymer
|
|
US20100080852A1
(en)
*
|
2007-05-03 |
2010-04-01 |
Ronald Arthur Beyerinck |
Phamaceutical composition comprising nanoparticles and casein
|
|
WO2008135828A2
(en)
*
|
2007-05-03 |
2008-11-13 |
Pfizer Products Inc. |
Nanoparticles comprising a drug, ethylcellulose, and a bile salt
|
|
EP2155166A2
(en)
*
|
2007-05-11 |
2010-02-24 |
F. Hoffmann-Roche AG |
Pharmaceutical compositions for poorly soluble drugs
|
|
US20080293814A1
(en)
*
|
2007-05-22 |
2008-11-27 |
Deepak Tiwari |
Concentrate esmolol
|
|
US8722736B2
(en)
*
|
2007-05-22 |
2014-05-13 |
Baxter International Inc. |
Multi-dose concentrate esmolol with benzyl alcohol
|
|
US8426467B2
(en)
*
|
2007-05-22 |
2013-04-23 |
Baxter International Inc. |
Colored esmolol concentrate
|
|
WO2008149192A2
(en)
*
|
2007-06-04 |
2008-12-11 |
Pfizer Products Inc. |
Nanoparticles comprising a non-ionizable cellulosic polymer and an amphiphilic non-ionizable block copolymer
|
|
AU2008259342B2
(en)
|
2007-06-04 |
2014-07-10 |
Ben-Gurion University Of The Negev Research And Development Authority |
Tri-aryl compounds and compositions comprising the same
|
|
WO2008149230A2
(en)
|
2007-06-04 |
2008-12-11 |
Pfizer Products Inc. |
Nanoparticles comprising drug, a non-ionizable cellulosic polymer and tocopheryl polyethylene glycol succinate
|
|
EP2167107B1
(en)
|
2007-06-22 |
2016-12-14 |
University of Maryland, Baltimore |
Inhibitors of ncca-atp channels for therapy
|
|
WO2009010842A2
(en)
*
|
2007-07-13 |
2009-01-22 |
Pfizer Products Inc. |
Nanoparticles comprising ionizable, poorly water soluble cellulosic polymers
|
|
US9683256B2
(en)
|
2007-10-01 |
2017-06-20 |
Longhorn Vaccines And Diagnostics, Llc |
Biological specimen collection and transport system
|
|
US11041215B2
(en)
|
2007-08-24 |
2021-06-22 |
Longhorn Vaccines And Diagnostics, Llc |
PCR ready compositions and methods for detecting and identifying nucleic acid sequences
|
|
US10004799B2
(en)
|
2007-08-27 |
2018-06-26 |
Longhorn Vaccines And Diagnostics, Llc |
Composite antigenic sequences and vaccines
|
|
CA2976814C
(en)
|
2007-08-27 |
2022-12-13 |
Longhorn Vaccines & Diagnostics, Llc |
Immunogenic compositions and methods for treating influenza
|
|
US20090130210A1
(en)
*
|
2007-09-11 |
2009-05-21 |
Raheja Praveen |
Pharmaceutical compositions of sirolimus
|
|
CL2008002775A1
(es)
|
2007-09-17 |
2008-11-07 |
Amgen Inc |
Uso de un agente de unión a esclerostina para inhibir la resorción ósea.
|
|
US11041216B2
(en)
|
2007-10-01 |
2021-06-22 |
Longhorn Vaccines And Diagnostics, Llc |
Compositions and methods for detecting and quantifying nucleic acid sequences in blood samples
|
|
EP2195466B1
(en)
|
2007-10-01 |
2012-10-10 |
Longhorn Vaccines & Diagnostics, LLC |
Method of storing biological specimens
|
|
EP3326621A1
(en)
*
|
2007-12-06 |
2018-05-30 |
Durect Corporation |
Oral pharmaceutical dosage forms
|
|
EP2240162A4
(en)
*
|
2007-12-06 |
2013-10-09 |
Bend Res Inc |
NANOTE PARTICLES WITH A NON-IONIZABLE POLYMER AND AN AMIN-FUNCTIONALIZED METHACRYLATE COPOLYMER
|
|
US9724362B2
(en)
*
|
2007-12-06 |
2017-08-08 |
Bend Research, Inc. |
Pharmaceutical compositions comprising nanoparticles and a resuspending material
|
|
US20090238867A1
(en)
*
|
2007-12-13 |
2009-09-24 |
Scott Jenkins |
Nanoparticulate Anidulafungin Compositions and Methods for Making the Same
|
|
EP2628486A3
(en)
|
2007-12-14 |
2013-10-30 |
Amgen, Inc. |
Method for treating bone fracture with anti-sclerostin antibodies
|
|
MX2010007076A
(es)
*
|
2007-12-24 |
2010-09-30 |
Sun Pharma Advanced Res Co Ltd |
Nanodispersion.
|
|
US8865223B2
(en)
*
|
2008-02-11 |
2014-10-21 |
Technion Research And Development Foundation Ltd. |
Beta-casein assemblies for mucosal delivery of therapeutic bioactive agents
|
|
US8871276B2
(en)
|
2008-02-11 |
2014-10-28 |
Technion Research And Development Foundation Ltd. |
Beta-casein assemblies for mucosal delivery of therapeutic bioactive agents
|
|
US20110045092A1
(en)
*
|
2008-02-11 |
2011-02-24 |
Livney Yoav D |
Casein particles encapsulating therapeutically active agents and uses thereof
|
|
US8865222B2
(en)
*
|
2008-02-11 |
2014-10-21 |
Technion Research And Development Foundation Ltd. |
Beta-casein assemblies for enrichment of food and beverages and methods of preparation thereof
|
|
JP2011520779A
(ja)
*
|
2008-03-21 |
2011-07-21 |
エラン・ファルマ・インターナショナル・リミテッド |
イマチニブの部位特異的送達のための組成物および使用の方法
|
|
US8258111B2
(en)
|
2008-05-08 |
2012-09-04 |
The Johns Hopkins University |
Compositions and methods related to miRNA modulation of neovascularization or angiogenesis
|
|
US20090311335A1
(en)
*
|
2008-06-12 |
2009-12-17 |
Scott Jenkins |
Combination of a triptan and an nsaid
|
|
EA020753B1
(ru)
*
|
2008-06-16 |
2015-01-30 |
Бинд Терапьютикс, Инк. |
Терапевтические полимерные наночастицы, содержащие алкалоиды vinca, и их применение
|
|
WO2009158649A1
(en)
|
2008-06-26 |
2009-12-30 |
Atyr Pharma, Inc. |
Compositions and methods comprising glycyl-trna synthetases having non-canonical biological activities
|
|
WO2010009075A1
(en)
*
|
2008-07-14 |
2010-01-21 |
The University Of North Carolina At Chapel Hill |
Methods and compositions comprising crystalline nanoparticles of hydrophobic compounds
|
|
EP2349237A4
(en)
*
|
2008-07-31 |
2012-07-25 |
Santosh Kumar Kar |
CURCUMIN NANOTEILS AND MANUFACTURING METHOD THEREFOR
|
|
CZ2008523A3
(cs)
*
|
2008-08-29 |
2009-10-14 |
Fyzikální ústav AV CR, v.v.i. |
Zpusob prípravy hybridních nanocástic z aglomerátu nanocástic komplexních vícesložkových oxidu kovu
|
|
EP2326318A4
(en)
|
2008-09-16 |
2012-05-23 |
Univ Maryland |
SUR1 HEMMER FOR THERAPEUTIC PURPOSES
|
|
US20100099775A1
(en)
*
|
2008-10-17 |
2010-04-22 |
Alpharx Inc. |
Method for ameliorating of post-anesthetic recovery
|
|
US20100260844A1
(en)
|
2008-11-03 |
2010-10-14 |
Scicinski Jan J |
Oral pharmaceutical dosage forms
|
|
US8349899B1
(en)
|
2008-12-03 |
2013-01-08 |
Arrowhead Center, Inc. |
Selective inhibitors of EG5 motors and methods of use
|
|
US8765817B1
(en)
|
2008-12-03 |
2014-07-01 |
Arrowhead Center, Inc. |
Selective inhibitors of EG5 motors and methods of use
|
|
LT2379096T
(lt)
|
2008-12-19 |
2019-12-27 |
Baxalta GmbH |
Tfpi inhibitoriai ir vartojimo būdai
|
|
US8962563B2
(en)
|
2009-12-21 |
2015-02-24 |
Baxter International, Inc. |
TFPI inhibitors and methods of use
|
|
RU2391104C1
(ru)
*
|
2008-12-29 |
2010-06-10 |
Зоя Ивановна Микашинович |
Способ лечения фетоплацентарной недостаточности
|
|
WO2010099508A1
(en)
|
2009-02-26 |
2010-09-02 |
Theraquest Biosciences, Inc. |
Extended release oral pharmaceutical compositions of 3-hydroxy-n-methylmorphinan and method of use
|
|
WO2010099477A2
(en)
|
2009-02-27 |
2010-09-02 |
Atyr Pharma, Inc. |
Polypeptide structural motifs associated with cell signaling activity
|
|
DK2408905T3
(en)
|
2009-03-16 |
2017-08-28 |
Pangu Biopharma Ltd |
Compositions and Methods comprising Histidyl-tRNA Synthetase Splicing Variants with Non-Canonical Biological Activities
|
|
WO2010120509A2
(en)
|
2009-03-31 |
2010-10-21 |
Atyr Pharma, Inc. |
Compositions and methods comprising aspartyl-trna synthetases having non-canonical biological activities
|
|
ES2702049T3
(es)
|
2009-04-24 |
2019-02-27 |
Univ Vanderbilt |
Inducción anti-TGF-beta de crecimiento óseo
|
|
WO2010135714A2
(en)
|
2009-05-22 |
2010-11-25 |
The Methodist Hospital Research Institute |
Methods for modulating adipocyte expression using microrna compositions
|
|
FR2945950A1
(fr)
|
2009-05-27 |
2010-12-03 |
Elan Pharma Int Ltd |
Compositions de nanoparticules anticancereuses et procedes pour les preparer
|
|
CA2763456C
(en)
|
2009-05-27 |
2017-10-24 |
Alkermes Pharma Ireland Limited |
Reduction of flake-like aggregation in nanoparticulate active agent compositions
|
|
WO2010138263A2
(en)
|
2009-05-28 |
2010-12-02 |
University Of Massachusetts |
Novel aav 's and uses thereof
|
|
KR20120050414A
(ko)
|
2009-06-19 |
2012-05-18 |
썬 파마 어드밴스트 리서치 컴패니 리미티드 |
약물의 나노분산액 및 그의 제조 방법
|
|
US10369256B2
(en)
|
2009-07-10 |
2019-08-06 |
Boston Scientific Scimed, Inc. |
Use of nanocrystals for drug delivery from a balloon
|
|
WO2011008737A2
(en)
|
2009-07-13 |
2011-01-20 |
The University Of North Carolina At Chapel Hill |
Engineered aerosol particles, and associated methods
|
|
WO2011011781A1
(en)
|
2009-07-24 |
2011-01-27 |
Baylor College Of Medicine |
Methods of modulation of branched chain acids and uses thereof
|
|
WO2011032180A1
(en)
|
2009-09-14 |
2011-03-17 |
Jennerex, Inc. |
Oncolytic vaccinia virus combination cancer therapy
|
|
US9045729B2
(en)
|
2009-12-10 |
2015-06-02 |
Ottawa Hospital Research Institute |
Oncolytic rhabdovirus
|
|
US20110150885A1
(en)
|
2009-12-11 |
2011-06-23 |
Atyr Pharma, Inc. |
Aminoacyl trna synthetases for modulating hematopoiesis
|
|
JP5819314B2
(ja)
|
2009-12-11 |
2015-11-24 |
エータイアー ファーマ， インコーポレイテッド |
炎症を調節するためのアミノアシルｔＲＮＡシンテターゼ
|
|
AU2010330794A1
(en)
|
2009-12-18 |
2012-06-21 |
Amgen Inc. |
Wise binding agents and epitopes
|
|
HRP20161608T1
(hr)
|
2010-01-27 |
2017-01-13 |
Glaxosmithkline Biologicals Sa |
Modificirani tuberkulozni antigeni
|
|
TWI438009B
(zh)
*
|
2010-02-19 |
2014-05-21 |
Teikoku Pharma Usa Inc |
紫杉烷前－乳劑調配物及其製造與使用之方法
|
|
EP2547355B1
(en)
|
2010-03-19 |
2017-01-11 |
Baxalta GmbH |
Tfpi inhibitors and methods of use
|
|
KR20190060881A
(ko)
|
2010-04-23 |
2019-06-03 |
유니버시티 오브 플로리다 리서치 파운데이션, 인크. |
레베르 선천성 흑내장-1(lca1)의 치료를 위한 재조합 아데노-관련된 바이러스-구아닐레이트 사이클라제 조성물 및 방법
|
|
DK2826860T3
(en)
|
2010-04-23 |
2018-12-03 |
Univ Massachusetts |
CNS targeting AAV vectors and methods for their use
|
|
EP2561075B1
(en)
|
2010-04-23 |
2018-06-27 |
University of Massachusetts |
Aav-based treatment of cholesterol-related disorders
|
|
CN103118692A
(zh)
|
2010-04-26 |
2013-05-22 |
Atyr医药公司 |
与半胱氨酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
|
|
CA2797362C
(en)
|
2010-04-27 |
2020-12-08 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of isoleucyl trna synthetases
|
|
CN103097524B
(zh)
|
2010-04-28 |
2016-08-03 |
Atyr医药公司 |
与丙氨酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
|
|
AU2011248457B2
(en)
|
2010-04-29 |
2017-02-16 |
Pangu Biopharma Limited |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of valyl tRNA synthetases
|
|
US8986680B2
(en)
|
2010-04-29 |
2015-03-24 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of Asparaginyl tRNA synthetases
|
|
SG185389A1
(en)
|
2010-05-03 |
2012-12-28 |
Teikoku Pharma Usa Inc |
Non-aqueous taxane pro-emulsion formulations and methods of making and using the same
|
|
ES2623805T3
(es)
|
2010-05-03 |
2017-07-12 |
Atyr Pharma, Inc. |
Descubrimiento innovador de composiciones terapéuticas, de diagnóstico y de anticuerpos relacionadas con fragmentos de proteínas de fenilalanil-alfa-ARNt sintetasas
|
|
EP2566496B1
(en)
|
2010-05-03 |
2018-02-28 |
aTyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of methionyl-trna synthetases
|
|
CN103096925A
(zh)
|
2010-05-03 |
2013-05-08 |
Atyr医药公司 |
与精氨酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
|
|
CN102985103A
(zh)
|
2010-05-04 |
2013-03-20 |
Atyr医药公司 |
与p38多-tRNA合成酶复合物相关的治疗、诊断和抗体组合物的创新发现
|
|
CA2799197C
(en)
|
2010-05-14 |
2019-10-29 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-beta-trna synthetases
|
|
SMT202000095T1
(it)
|
2010-05-14 |
2020-03-13 |
Amgen Inc |
Formulazioni di anticorpi anti-sclerostina ad alta concentrazione
|
|
CA2799480C
(en)
|
2010-05-17 |
2020-12-15 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of leucyl-trna synthetases
|
|
CA2800375C
(en)
|
2010-05-27 |
2021-03-09 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutaminyl-trna synthetases
|
|
CN103118694B
(zh)
|
2010-06-01 |
2016-08-03 |
Atyr医药公司 |
与赖氨酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的发现
|
|
AU2011289831C1
(en)
|
2010-07-12 |
2017-06-15 |
Pangu Biopharma Limited |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-tRNA synthetases
|
|
EP3636778B1
(en)
|
2010-08-18 |
2022-01-12 |
Fred Hutchinson Cancer Research Center |
Agents for use in treating facioscapulohumeral dystrophy (fshd)
|
|
AU2011293294B2
(en)
|
2010-08-25 |
2016-03-24 |
Pangu Biopharma Limited |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of Tyrosyl-tRNA synthetases
|
|
WO2012057904A1
(en)
|
2010-10-27 |
2012-05-03 |
Infectious Disease Research Institute |
Mycobacterium tuberculosis antigens and combinations thereof having high seroreactivity
|
|
EA201390676A1
(ru)
|
2010-11-08 |
2013-11-29 |
Инфекшес Дизиз Рисерч Инститьют |
Вакцины, содержащие полипептиды неспецифической нуклеозидгидролазы и стерол 24-c-метилтрансферазы (smt), для лечения и диагностики лейшманиоза
|
|
EP2661278B1
(en)
|
2011-01-04 |
2019-06-19 |
SillaJen Biotherapeutics, Inc. |
Tumor specific complement dependent cytotoxicity (cdc) antibodies generated by administration of oncolytic vaccinia virus, for use in the treatment of cancer
|
|
US9403885B2
(en)
|
2011-01-11 |
2016-08-02 |
Fate Therapeutics, Inc. |
Wnt compositions and therapeutic uses of such compositions
|
|
WO2012103328A1
(en)
|
2011-01-26 |
2012-08-02 |
The Methodist Hospital Research Institute |
Labeled, non- peptidic multivalent integrin alpha -v - beta - 3 antagonists, compositions containing them and their use
|
|
MX2013008944A
(es)
|
2011-02-03 |
2014-01-08 |
Mirna Therapeutics Inc |
Mimeticos sinteticos de mir-124.
|
|
EP3178932A1
(en)
|
2011-02-03 |
2017-06-14 |
Mirna Therapeutics, Inc. |
Synthetic mimics of mir-34
|
|
CN103391769A
(zh)
|
2011-02-17 |
2013-11-13 |
霍夫曼-拉罗奇有限公司 |
通过热熔挤出使活性药物成分从过冷液体状态受控结晶的方法
|
|
US9133272B2
(en)
|
2011-03-01 |
2015-09-15 |
Amgen Inc. |
Bispecific binding agents
|
|
JP2014511842A
(ja)
|
2011-03-25 |
2014-05-19 |
アムジエン・インコーポレーテツド |
抗スクレロスチン抗体結晶およびその製剤
|
|
HUE052094T2
(hu)
|
2011-04-19 |
2021-04-28 |
Amgen Inc |
Osteoporosis kezelési módszere
|
|
AU2012255143A1
(en)
|
2011-05-19 |
2014-02-20 |
The Regents Of The University Of Michigan |
Integrin alpha-2 binding agents and use thereof to inhibit cancer cell proliferation
|
|
WO2012170384A1
(en)
|
2011-06-06 |
2012-12-13 |
Chevron Phillips Chemical Company Lp |
Use of metallocene compounds for cancer treatment
|
|
WO2012167382A1
(en)
|
2011-06-08 |
2012-12-13 |
Children's Hospital Of Eastern Ontario Research Institute Inc. |
Compositions and methods for glioblastoma treatment
|
|
TR201819015T4
(tr)
|
2011-06-10 |
2019-01-21 |
Bluebird Bio Inc |
Adrenolökodi̇strofi̇ ve adrenomi̇yelonöropati̇ i̇çi̇n gen terapi̇ vektörleri̇
|
|
AU2012273153A1
(en)
|
2011-06-21 |
2013-05-02 |
Oncofactor Corporation |
Compositions and methods for the therapy and diagnosis of cancer
|
|
ES2751388T3
(es)
|
2011-07-22 |
2020-03-31 |
Univ Chicago |
IGF-1 para su uso en el tratamiento de la jaqueca
|
|
DK2739311T3
(en)
|
2011-08-04 |
2018-04-23 |
Amgen Inc |
Method of treating bone slit defects
|
|
WO2013057592A2
(en)
|
2011-09-14 |
2013-04-25 |
King Abdullah University Of Science And Technology |
Treatment of sickle cell disease
|
|
US9644005B2
(en)
|
2011-09-21 |
2017-05-09 |
King Abdullah University Of Science And Technology |
Didemnin biosynthetic gene cluster in Tistrella mobilis
|
|
WO2013043196A1
(en)
|
2011-09-23 |
2013-03-28 |
Bluebird Bio, Inc. |
Improved gene therapy methods
|
|
WO2013095736A2
(en)
|
2011-09-27 |
2013-06-27 |
The Methodist Hospital Research Institute |
Gold-in-silicon nanoassembly for thermal therapy and methods of use
|
|
EP3269802B1
(en)
|
2011-09-30 |
2019-10-23 |
Bluebird Bio, Inc. |
Compounds for improved viral transduction
|
|
CA2887928A1
(en)
|
2011-10-31 |
2013-10-10 |
The Methodist Hospital Research Institute |
Compound comprising a mao targeting/seeker moiety for treating human gliomas
|
|
JP6368243B2
(ja)
|
2011-11-11 |
2018-08-08 |
フレッド ハッチンソン キャンサー リサーチ センター |
がんのためのサイクリンａ１に標的化されたｔ細胞免疫療法
|
|
WO2013074988A1
(en)
|
2011-11-17 |
2013-05-23 |
The Regents Of The University Of Colorado, A Body Corporate |
Methods and compositions for enhanced drug delivery to the eye and extended delivery formulations
|
|
US20130177627A1
(en)
*
|
2011-11-18 |
2013-07-11 |
Linda Einbond |
Growth inhibitory effects of nanoparticles containing triterpene glycosides or triterpenes
|
|
US9546367B2
(en)
|
2011-12-07 |
2017-01-17 |
Jenny Chee Ning Chang |
siRNA compositions and methods for inhibiting gene expression in tumor initiating cells of breast cancer
|
|
EA036740B1
(ru)
|
2011-12-28 |
2020-12-15 |
Эмджен Инк. |
Способ увеличения высоты альвеолярного отростка посредством применения антител к склеростину
|
|
EP2806890A4
(en)
|
2012-01-26 |
2015-09-02 |
Longhorn Vaccines & Diagnostics Llc |
COMPOSITIONAL ANTIGEN SEQUENCES AND VACCINES
|
|
EP2852413A4
(en)
|
2012-02-16 |
2016-04-27 |
Univ Toledo |
XENOANTIGEN WITH VACCINES AGAINST CANCER AND MANUFACTURING PROCESS THEREFOR
|
|
US20140128431A1
(en)
|
2012-04-03 |
2014-05-08 |
Hoffmann-Laroche Inc. |
Pharmaceutical composition with improved bioavailability, safety and tolerability
|
|
AR092821A1
(es)
|
2012-04-20 |
2015-05-06 |
Sucampo Ag |
Conjugado de derivado de acido graso-polimero
|
|
AU2013266232B2
(en)
|
2012-05-23 |
2017-08-03 |
The Ohio State University |
Lipid nanoparticle compositions for antisense oligonucleotides delivery
|
|
WO2014006100A1
(en)
|
2012-07-05 |
2014-01-09 |
Ucb Pharma S.A. |
Treatment for bone diseases
|
|
EP2880053B8
(en)
|
2012-08-01 |
2020-04-15 |
Ikaika Therapeutics, LLC |
Mitigating tissue damage and fibrosis via anti-ltbp4 antibody
|
|
PT2879701T
(pt)
|
2012-08-03 |
2024-02-12 |
Access To Advanced Health Inst |
Composições e métodos para o tratamento de uma infeção ativa por mycobacterium tuberculosis
|
|
JP6486272B2
(ja)
|
2012-09-07 |
2019-03-20 |
マサチューセッツ・アイ・アンド・イア・インファーマリー |
有毛細胞および／または支持細胞再生のための方法および組成物
|
|
JO3685B1
(ar)
|
2012-10-01 |
2020-08-27 |
Teikoku Pharma Usa Inc |
صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها
|
|
UY35148A
(es)
|
2012-11-21 |
2014-05-30 |
Amgen Inc |
Immunoglobulinas heterodiméricas
|
|
UA116004C2
(uk)
|
2013-01-22 |
2018-01-25 |
Ф. Хоффманн-Ля Рош Аг |
Фармацевтична композиція з покращеною біодоступністю
|
|
AU2014212014A1
(en)
|
2013-02-01 |
2015-08-27 |
Amgen Inc. |
Administration of an anti-activin-A compound to a subject
|
|
WO2014127478A1
(en)
|
2013-02-21 |
2014-08-28 |
Children's Hospital Of Eastern Ontario Research Institute Inc. |
Vaccine composition
|
|
WO2014160339A1
(en)
|
2013-03-13 |
2014-10-02 |
Board Of Regents, The University Of Texas System |
Compounds for treating inflammatory and hyperproliferative diseases
|
|
US9572885B2
(en)
|
2013-03-15 |
2017-02-21 |
Durect Corporation |
Compositions with a rheological modifier to reduce dissolution variability
|
|
US9909114B2
(en)
|
2013-03-28 |
2018-03-06 |
Infectious Disease Research Institute |
Vaccines comprising leishmania polypeptides for the treatment and diagnosis of leishmaniasis
|
|
US9393202B2
(en)
*
|
2013-04-26 |
2016-07-19 |
Chiesi Farmaceutici S.P.A |
Particle size reduction of an antimuscarinic compound
|
|
WO2014186746A1
(en)
|
2013-05-16 |
2014-11-20 |
University Of Florida Research Foundation, Inc. |
HAIRPIN mRNA ELEMENTS AND METHODS FOR THE REGULATION OF PROTEIN TRANSLATION
|
|
WO2015068156A1
(en)
|
2013-11-05 |
2015-05-14 |
Ben-Gurion University Of The Negev Research And Development Authority |
Compounds for the treatment of diabetes and disease complications arising from same
|
|
NZ720311A
(en)
|
2013-12-02 |
2022-10-28 |
Baylor College Medicine |
Identification of a new polypeptide hormone for maintenance of optimal body weight and blood glucose
|
|
TWI731535B
(zh)
|
2014-03-21 |
2021-06-21 |
美商艾伯維有限公司 |
抗-egfr抗體及抗體藥物結合物
|
|
WO2015157471A1
(en)
|
2014-04-08 |
2015-10-15 |
The Methodist Hospital |
Inos-inhibitory compositions and their use as breast cancer therapeutics
|
|
WO2015157500A1
(en)
|
2014-04-09 |
2015-10-15 |
Research Development Foundation |
Class iia hdac inhibitors for the treatment of infection
|
|
WO2015164786A1
(en)
|
2014-04-25 |
2015-10-29 |
University Of Massachusetts |
Recombinant aav vectors useful for reducing immunity against transgene products
|
|
US20170137505A1
(en)
|
2014-06-20 |
2017-05-18 |
Aveo Pharmaceuticals, Inc. |
Treatment of congestive heart failure and other cardiac dysfunction using a gdf15 modulator
|
|
CA2952032C
(en)
|
2014-06-20 |
2023-03-14 |
Aveo Pharmaceuticals, Inc. |
Treatment of chronic kidney disease and other renal dysfunction using a gdf15 modulator
|
|
US10278986B2
(en)
|
2014-08-14 |
2019-05-07 |
The Regents Of The University Of Colorado, A Body Corporate |
Antibody-siRNA conjugates and uses therefor
|
|
EP3188600B1
(en)
|
2014-09-01 |
2022-05-11 |
Academia Sinica |
Animal model of longevity and related methods for increasing longevity and inhibiting tumorigenesis
|
|
KR20230030002A
(ko)
|
2014-09-04 |
2023-03-03 |
메모리얼 슬로안 케터링 캔서 센터 |
헤모글로빈병증 치료용 글로빈 유전자 치료법
|
|
PL3197493T3
(pl)
|
2014-09-25 |
2021-08-23 |
Aveo Pharmaceuticals Inc. |
Sposoby odwracania kacheksji i przedłużania przeżycia obejmujące podanie modulatora gdf15 i środka przeciwnowotworowego
|
|
EP3795580A1
(en)
|
2014-10-03 |
2021-03-24 |
University of Massachusetts |
High efficiency library-identified aav vectors
|
|
WO2016065001A1
(en)
|
2014-10-21 |
2016-04-28 |
University Of Massachusetts |
Recombinant aav variants and uses thereof
|
|
US10302644B2
(en)
|
2014-11-04 |
2019-05-28 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for treating multiple myeloma
|
|
MA41142A
(fr)
|
2014-12-12 |
2017-10-17 |
Amgen Inc |
Anticorps anti-sclérostine et utilisation de ceux-ci pour traiter des affections osseuses en tant qu'élements du protocole de traitement
|
|
CN107249646B
(zh)
|
2014-12-16 |
2021-06-29 |
内布拉斯加大学董事会 |
用于青少年巴滕病的基因疗法
|
|
US10166197B2
(en)
|
2015-02-13 |
2019-01-01 |
St. John's University |
Sugar ester nanoparticle stabilizers
|
|
JP2018509164A
(ja)
|
2015-03-10 |
2018-04-05 |
ザ・トラスティーズ・オブ・コロンビア・ユニバーシティ・イン・ザ・シティ・オブ・ニューヨーク |
組換えＧｌｕｔ１アデノ随伴ウイルスベクターコンストラクトおよびＧｌｕｔ１発現を回復させる方法
|
|
EP3285792B1
(en)
|
2015-04-20 |
2020-11-04 |
The Board of Regents of The University of Texas System |
Clec11a is a bone growth agent
|
|
EP4491733A3
(en)
|
2015-04-23 |
2025-03-26 |
University of Massachusetts |
Modulation of aav vector transgene expression
|
|
CN107709344B
(zh)
|
2015-05-01 |
2022-07-15 |
共晶制药股份有限公司 |
用于治疗黄病毒科病毒和癌症的核苷类似物
|
|
CA2985652C
(en)
|
2015-05-14 |
2020-03-10 |
Gerald W. FISHER |
Rapid methods for the extraction of nucleic acids from biological samples
|
|
EP3302423B1
(en)
|
2015-06-04 |
2022-05-25 |
Crititech, Inc. |
Particle production system and particle collection device
|
|
US10962551B2
(en)
|
2015-06-17 |
2021-03-30 |
The Johns Hopkins University |
TDP-43 in degenerative disease
|
|
KR102742522B1
(ko)
|
2015-09-16 |
2024-12-12 |
디에프비 소리아, 엘엘씨 |
약물 나노입자 전달체 및 이의 제조방법
|
|
JP6720977B2
(ja)
*
|
2015-09-28 |
2020-07-08 |
住友大阪セメント株式会社 |
食器洗い乾燥機の製造方法
|
|
EP3362042A1
(en)
|
2015-10-16 |
2018-08-22 |
Marinus Pharmaceuticals, Inc. |
Injectable neurosteroid formulations containing nanoparticles
|
|
WO2017070525A1
(en)
|
2015-10-22 |
2017-04-27 |
University Of Massachusetts |
Methods and compositions for treating metabolic imbalance in neurodegenerative disease
|
|
KR20180104597A
(ko)
|
2015-11-07 |
2018-09-21 |
멀티비르 인코포레이티드 |
암 치료를 위한 종양 억제 유전자 요법 및 면역관문 봉쇄를 포함하는 조성물
|
|
AR107469A1
(es)
|
2016-01-27 |
2018-05-02 |
Oncorus Inc |
Vectores virales oncolíticos y sus usos
|
|
US10695322B2
(en)
|
2016-01-29 |
2020-06-30 |
The Johns Hopkins University |
Inhibitors of bacterial growth
|
|
EP3411059A4
(en)
|
2016-02-02 |
2019-10-16 |
University Of Massachusetts |
METHOD FOR INCREASING THE EFFECTIVENESS OF THE SYSTEMIC DELIVERY OF AVV GENES TO THE CENTRAL NERVOUS SYSTEM
|
|
EP3413928B1
(en)
|
2016-02-12 |
2022-04-20 |
University of Massachusetts |
Anti-angiogenic mirna therapeutics for inhibiting corneal neovascularization
|
|
US11040025B2
(en)
|
2016-02-17 |
2021-06-22 |
The Johns Hopkins University |
Oxazolidinone for treatment of infections with Mycobacterium tuberculosis
|
|
EP3419602A1
(en)
|
2016-02-22 |
2019-01-02 |
The Methodist Hospital |
Biomimetic proteolipid vesicle compositions and uses thereof
|
|
WO2017147370A1
(en)
|
2016-02-24 |
2017-08-31 |
The Johns Hopkins University |
Novel antiviral proteins and their uses in therapeutic methods
|
|
AU2017225769B2
(en)
|
2016-03-02 |
2023-01-05 |
The Board Of Regents Of The University Of Texas System |
Sting activating nanovaccine for immunotherapy
|
|
EP3423110B1
(en)
|
2016-03-03 |
2021-08-11 |
University of Massachusetts |
Closed-ended linear duplex dna for non-viral gene transfer
|
|
WO2017155935A1
(en)
|
2016-03-07 |
2017-09-14 |
The Johns Hopkins University |
Pharmaceutical agents targeting cancer stem cells
|
|
US11203626B2
(en)
|
2016-03-10 |
2021-12-21 |
The Johns Hopkins University |
Methods of producing aggregate-free monomeric diphtheria toxin fusion proteins and therapeutic uses
|
|
US11965009B2
(en)
|
2016-03-10 |
2024-04-23 |
The Johns Hopkins University |
Methods of producing aggregate-free monomeric diphtheria toxin fusion proteins and therapeutic uses
|
|
BR112018068055A2
(pt)
|
2016-03-10 |
2019-01-08 |
Univ Johns Hopkins |
métodos para produção de proteínas de fusão de toxina da difteria monoméricas livre de agregados e usos terapêuticas
|
|
GB201604124D0
(en)
|
2016-03-10 |
2016-04-27 |
Ucb Biopharma Sprl |
Pharmaceutical formulation
|
|
KR102889062B1
(ko)
|
2016-03-17 |
2025-11-21 |
더 존스 홉킨스 유니버시티 |
Paris의 파네실화에 의해 파킨슨병을 예방 또는 치료하기 위한 방법
|
|
EP3436609B1
(en)
|
2016-03-30 |
2022-05-04 |
The Johns Hopkins University |
Olfr90 specificity and methods of detection
|
|
WO2017176628A1
(en)
|
2016-04-04 |
2017-10-12 |
Crititech, Inc. |
Methods for solid tumor treatment
|
|
WO2017189483A1
(en)
|
2016-04-25 |
2017-11-02 |
The Johns Hopkins University |
Znt8 assays for drug development and pharmaceutical compositions
|
|
EP3458088A2
(en)
|
2016-05-21 |
2019-03-27 |
Infectious Disease Research Institute |
Compositions and methods for treating secondary tuberculosis and nontuberculous mycobacterium infections
|
|
AU2017277914A1
(en)
|
2016-06-08 |
2019-01-03 |
Abbvie Inc. |
Anti-CD98 antibodies and antibody drug conjugates
|
|
JP2019526529A
(ja)
|
2016-06-08 |
2019-09-19 |
アッヴィ・インコーポレイテッド |
抗ｂ７−ｈ３抗体及び抗体薬物コンジュゲート
|
|
CN109641962A
(zh)
|
2016-06-08 |
2019-04-16 |
艾伯维公司 |
抗b7-h3抗体和抗体药物偶联物
|
|
BR112018075644A2
(pt)
|
2016-06-08 |
2019-04-09 |
Abbvie Inc. |
anticorpos anti-cd98 e conjugados de anticorpo e fármaco
|
|
RS61828B1
(sr)
|
2016-06-08 |
2021-06-30 |
Abbvie Inc |
Anti-b7-h3 antitela i antitelske konjugacije lekova
|
|
KR20190096329A
(ko)
|
2016-07-05 |
2019-08-19 |
유니버시티 오브 매사추세츠 |
녹내장에서 신경보호 요법으로서 sfasl의 aav2-매개된 유전자 전달
|
|
SG11201811760VA
(en)
|
2016-07-06 |
2019-01-30 |
Durect Corp |
Oral dosage form with drug composition, barrier layer and drug layer
|
|
WO2018017747A2
(en)
|
2016-07-19 |
2018-01-25 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Oncolytic viruses targeting stat3
|
|
WO2018031748A1
(en)
|
2016-08-11 |
2018-02-15 |
Ovid Therapeutics Inc. |
Methods and compositions for treatment of epileptic disorders
|
|
US9963498B2
(en)
|
2016-08-18 |
2018-05-08 |
Wisconsin Alumni Research Foundation |
Peptides that inhibit syndecan-1 activation of VLA-4 and IGF-1R
|
|
US10391105B2
(en)
|
2016-09-09 |
2019-08-27 |
Marinus Pharmaceuticals Inc. |
Methods of treating certain depressive disorders and delirium tremens
|
|
MX2019003035A
(es)
|
2016-09-16 |
2019-09-13 |
Infectious Disease Res Inst |
Vacunas que comprenden polipeptidos de mycobacterium leprae para la prevencion, el tratamiento y el diagnostico de la lepra.
|
|
US10457940B2
(en)
|
2016-09-22 |
2019-10-29 |
University Of Massachusetts |
AAV treatment of Huntington's disease
|
|
US11149275B2
(en)
|
2016-10-10 |
2021-10-19 |
The Johns Hopkins University |
Device and method to treat esophageal disorders
|
|
US11578340B2
(en)
|
2016-10-13 |
2023-02-14 |
University Of Massachusetts |
AAV capsid designs
|
|
EP3538553A4
(en)
|
2016-11-08 |
2020-11-25 |
University of Miami |
ANTI-SECRETOGRANIN III (SCG3) ANTIBODIES AND THEIR USES
|
|
JP2020510624A
(ja)
|
2016-12-12 |
2020-04-09 |
マルチビア インコーポレイテッド |
がんおよび感染性疾患の治療および予防のための、ウイルス遺伝子治療および免疫チェックポイント阻害剤を含む方法および組成物
|
|
US10434089B2
(en)
|
2017-01-25 |
2019-10-08 |
The Johns Hopkins University |
Avibactam and carbapenems antibacterial agents
|
|
CA3051136A1
(en)
|
2017-01-27 |
2018-08-02 |
The Methodist Hospital |
Core/shell structure platform for immunotherapy
|
|
US12350303B2
(en)
|
2017-02-03 |
2025-07-08 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
Oncolytic virus therapy
|
|
AU2018218003B2
(en)
|
2017-02-12 |
2024-02-08 |
Neuromagen Pharma Ltd. |
Telomerase activating compounds for use in fertility and related applications
|
|
CN116003564A
(zh)
|
2017-03-14 |
2023-04-25 |
贝勒医学院 |
作为Hippo效应子的显性活性Yap诱导染色质可及性和心肌细胞更新
|
|
JP2020514359A
(ja)
|
2017-03-15 |
2020-05-21 |
ディーエフビー ソリア リミテッド ライアビリティ カンパニー |
タキサンのナノ粒子を用いる皮膚悪性腫瘍処置のための局所療法
|
|
CN118360335A
(zh)
|
2017-04-05 |
2024-07-19 |
马萨诸塞大学 |
小基因治疗
|
|
US20210139932A1
(en)
|
2017-05-03 |
2021-05-13 |
Biomarin Pharmaceutical Inc. |
Improved lentiviruses for transduction of hematopoietic stem cells
|
|
BR112019025732A2
(pt)
|
2017-06-06 |
2020-06-30 |
University Of Massachusetts |
vetores de aav auto-reguladores para expressão segura de mecp2 na síndrome de rett
|
|
BR112019023948A2
(pt)
|
2017-06-09 |
2020-06-09 |
Crititech Inc |
tratamento de cistos epiteliais por injeção intracística de partículas antineoplásicas
|
|
EP3615004B1
(en)
*
|
2017-06-14 |
2025-02-19 |
Crititech, Inc. |
Methods for treating lung disorders
|
|
US11892457B2
(en)
|
2017-07-12 |
2024-02-06 |
The Johns Hopkins University |
Proteoliposome-based ZnT8 self-antigen for type 1 diabetes diagnosis
|
|
EP3658165A4
(en)
|
2017-07-26 |
2021-09-01 |
Oncorus, Inc. |
ONCOLYTIC VIRAL VECTORS AND THEIR USES
|
|
WO2019028469A1
(en)
|
2017-08-04 |
2019-02-07 |
The Methodist Hospital |
FUNCTIONALIZED POLYMER MITOCHONDRIAL COMPOSITIONS AND METHODS OF USE IN CELL TRANSPLANTATION AND FOR MODIFYING METABOLIC PHENOTYPE
|
|
CA3078223A1
(en)
|
2017-09-08 |
2019-03-14 |
Infectious Disease Research Institute |
Liposomal formulations comprising saponin and methods of use
|
|
JP7792750B2
(ja)
|
2017-10-03 |
2025-12-26 |
クリティテック・インコーポレイテッド |
癌の治療のための免疫療法剤の全身送達と組み合わせた抗腫瘍粒子の局所送達
|
|
US20200330541A1
(en)
|
2017-11-16 |
2020-10-22 |
University Of Maine System Board Of Trustees |
Compositions and methods for modulating endothelial cell migration and angiogenesis
|
|
CA3084186A1
(en)
|
2017-12-06 |
2019-06-13 |
Memorial Sloan-Kettering Cancer Center |
Globin gene therapy for treating hemoglobinopathies
|
|
KR20200106515A
(ko)
|
2018-01-05 |
2020-09-14 |
오타와 하스피털 리서치 인스티튜트 |
변형된 백시니아 벡터
|
|
WO2019173478A2
(en)
|
2018-03-06 |
2019-09-12 |
The Johns Hopkins University |
Methods of treating or preventing cancer with an agent that depletes tregs and a checkpoint inhibitor
|
|
EP3765035A4
(en)
|
2018-03-16 |
2021-10-27 |
DFB Soria, LLC |
TOPICAL THERAPY FOR THE TREATMENT OF CERVICAL INTRAEPITHELIAL NEOPLASIA (CIN) AND COLD CANCER USING TAXANE NANOPARTICLES
|
|
US12454561B2
(en)
|
2018-03-19 |
2025-10-28 |
Multivir Inc. |
Methods and compositions comprising tumor suppressor gene therapy and CD122/CD132 agonists for the treatment of cancer
|
|
KR20200135433A
(ko)
|
2018-03-23 |
2020-12-02 |
유니버시티 오브 매사추세츠 |
골 장애 치료를 위한 유전자 치료제
|
|
CN119241705A
(zh)
|
2018-03-30 |
2025-01-03 |
安姆根有限公司 |
C末端抗体变体
|
|
US12054724B2
(en)
|
2018-04-10 |
2024-08-06 |
President And Fellows Of Harvard College |
AAV vectors encoding clarin-1 or GJB2 and uses thereof
|
|
US11472848B2
(en)
|
2018-04-27 |
2022-10-18 |
University Of Massachusetts |
AAV capsids identified by in vivo library selection
|
|
US20210207168A1
(en)
|
2018-05-08 |
2021-07-08 |
Rutgers, The State University Of New Jersey |
Aav-compatible laminin-linker polymerization proteins
|
|
KR102167755B1
(ko)
|
2018-05-23 |
2020-10-19 |
주식회사 큐어바이오 |
단편화된 grs 폴리펩타이드, 이의 변이체 및 이들의 용도
|
|
CN112770735A
(zh)
|
2018-07-29 |
2021-05-07 |
Musc研究发展基金会 |
用于治疗神经或线粒体疾病的化合物
|
|
WO2020033130A1
(en)
|
2018-08-06 |
2020-02-13 |
The Johns Hopkins University |
Treatment of irritable bowel syndrome with molybdenum
|
|
US12103968B2
(en)
|
2018-08-16 |
2024-10-01 |
The Johns Hopkins University |
Antibodies to human ZnT8
|
|
CN113453702A
(zh)
|
2018-09-28 |
2021-09-28 |
哈佛大学的校长及成员们 |
细胞重编程以逆转衰老并促进组织和组织再生
|
|
CA3113470A1
(en)
|
2018-09-28 |
2020-04-02 |
President And Fellows Of Harvard College |
Mutant reverse tetracycline transactivators for expression of genes
|
|
US12274733B2
(en)
|
2018-09-28 |
2025-04-15 |
President And Fellows Of Harvard College |
Cellular reprogramming to reverse aging and promote organ and tissue regeneration
|
|
AU2019358806B2
(en)
|
2018-10-08 |
2025-06-05 |
Allen Institute |
Artificial expression constructs for selectively modulating gene expression in interneurons
|
|
EP3887522A1
(en)
|
2018-11-29 |
2021-10-06 |
University of Massachusetts |
Modulation of sptlc1 via recombinant adeno-associated vectors
|
|
WO2020114615A1
(en)
|
2018-12-07 |
2020-06-11 |
Baxalta GmbH |
Bispecific antibodies binding factor ixa and factor x
|
|
WO2020118142A1
(en)
|
2018-12-07 |
2020-06-11 |
Marinus Pharmaceuticals, Inc. |
Ganaxolone for use in prophylaxis and treatment of pospartum depression
|
|
WO2020115283A1
(en)
|
2018-12-07 |
2020-06-11 |
Baxalta GmbH |
Bispecific antibodies binding factor ixa and factor x
|
|
CA3124415A1
(en)
|
2018-12-21 |
2020-06-25 |
Northwestern University |
Use of annexins in preventing and treating muscle membrane injury
|
|
US20220062299A1
(en)
|
2018-12-26 |
2022-03-03 |
Northwestern University |
Use of glucocorticoid steroids in preventing and treating conditions of muscle wasting, aging and metabolic disorder
|
|
CA3126544A1
(en)
|
2019-01-12 |
2020-07-16 |
The Methodist Hospital |
Self-assembled peptide nanoparticle and use thereof
|
|
EP3921029B1
(en)
|
2019-02-07 |
2025-07-30 |
Baylor College of Medicine |
Composition comprising ccl5 for use in treating bone break, bone fracture, bone degeneration and osteoporosis
|
|
US20220054655A1
(en)
|
2019-02-22 |
2022-02-24 |
University Of Massachusetts |
Oxr1 gene therapy
|
|
CN113710693B
(zh)
|
2019-02-25 |
2025-07-15 |
马萨诸塞大学 |
Dna结合结构域反式激活因子及其用途
|
|
US12553063B2
(en)
|
2019-04-12 |
2026-02-17 |
University Of Massachusetts |
CAS13 family AAV vectors and uses thereof
|
|
US12553036B2
(en)
|
2019-04-12 |
2026-02-17 |
University Of Massachusetts |
GM3 synthase vectors and uses thereof
|
|
CA3137135A1
(en)
|
2019-04-19 |
2020-10-22 |
University Of Massachusetts |
Gene therapies for stargardt disease (abca4)
|
|
WO2020219990A1
(en)
|
2019-04-26 |
2020-10-29 |
President And Fellows Of Harvard College |
Aav vectors encoding mini-pcdh15 and uses thereof
|
|
US11717506B2
(en)
|
2019-05-07 |
2023-08-08 |
The Johns Hopkins University |
Neuroprotective compounds for amyotrophic lateral sclerosis
|
|
EP3972569A1
(en)
*
|
2019-05-23 |
2022-03-30 |
Helm AG |
Nanoparticles comprising enzalutamide
|
|
EP3980400B1
(en)
|
2019-06-05 |
2025-08-06 |
Emory University |
Peptidomimetics for the treatment of coronavirus and picornavirus infections
|
|
CA3145923A1
(en)
|
2019-08-05 |
2021-02-11 |
David Czekai |
Ganaxolone for use in treatment of status epilepticus
|
|
AU2020346062A1
(en)
|
2019-09-13 |
2022-03-24 |
Rutgers, The State University Of New Jersey |
AAV-compatible laminin-linker polymerization proteins
|
|
US12366570B2
(en)
|
2019-10-01 |
2025-07-22 |
The Johns Hopkins University |
Cell-based ZNT8 assay
|
|
AU2020364144A1
(en)
|
2019-10-10 |
2022-05-26 |
Virogin Biotech Canada Ltd |
Dual viruses and dual oncolytic viruses and methods of treatment
|
|
US20230121437A1
(en)
|
2019-10-15 |
2023-04-20 |
University Of Massachusetts |
Rna editor-enhanced rna trans-splicing
|
|
WO2021113644A1
(en)
|
2019-12-05 |
2021-06-10 |
Multivir Inc. |
Combinations comprising a cd8+ t cell enhancer, an immune checkpoint inhibitor and radiotherapy for targeted and abscopal effects for the treatment of cancer
|
|
WO2021113834A1
(en)
|
2019-12-06 |
2021-06-10 |
Marinus Pharmaceuticals, Inc. |
Ganaxolone for use in treating tuberous sclerosis complex
|
|
CA3164937A1
(en)
|
2019-12-26 |
2021-07-01 |
Figene, Llc |
Prevention and treatment of kidney failure by administration of fibroblasts and products thereof
|
|
US20230026352A1
(en)
|
2019-12-26 |
2023-01-26 |
Figene, Llc |
Suppression of interleukin-17 production and inhibition of th17 cell generation by fibroblasts and products thereof
|
|
EP4090353A4
(en)
|
2020-01-13 |
2023-08-09 |
Durect Corporation |
DELAYED-RELEASE DRUG DELIVERY SYSTEMS WITH REDUCED IMPURITIES AND RELATED PROCEDURES
|
|
JP2023512071A
(ja)
|
2020-01-30 |
2023-03-23 |
ウモジャ バイオファーマ， インコーポレイテッド |
二特異性形質導入エンハンサー
|
|
US12485166B2
(en)
|
2020-02-06 |
2025-12-02 |
Longhorn Vaccines And Diagnostics, Llc |
Vaccines for the treatment and prevention of zoonotic infections
|
|
US20230089312A1
(en)
|
2020-02-25 |
2023-03-23 |
University Of Massachusetts |
Inducible single aav system and uses thereof
|
|
AU2021230540A1
(en)
|
2020-03-04 |
2022-10-13 |
Pleopharma, L.L.C. |
Methods and compositions for treating cannabis use disorder and mitigating cannabinoid withdrawal
|
|
TW202204377A
(zh)
|
2020-03-31 |
2022-02-01 |
麻州大學 |
蛋白殼變體及其用途
|
|
US11965162B2
(en)
|
2020-04-16 |
2024-04-23 |
The Johns Hopkins University |
MicroRNA and inhibitors thereof and methods of treatment
|
|
WO2021248085A2
(en)
|
2020-06-04 |
2021-12-09 |
Allen Institute |
Artificial expression constructs for selectively modulating gene expression in inhibitory neocortical neurons
|
|
MX2023001586A
(es)
|
2020-08-07 |
2023-05-03 |
Access To Advanced Health Inst |
Saponinas purificadas y proceso cromatografico para purificacion de las mismas.
|
|
US12129287B2
(en)
|
2020-09-14 |
2024-10-29 |
President And Fellows Of Harvard College |
Recombinant adeno associated virus encoding clarin-1 and uses thereof
|
|
WO2022087122A1
(en)
|
2020-10-20 |
2022-04-28 |
Longhorn Vaccines And Diagnostics, Llc |
Immunogenic antigens
|
|
WO2022087270A1
(en)
|
2020-10-23 |
2022-04-28 |
Mirati Therapeutics, Inc. |
Methods for treatment of lung cancers
|
|
US11674154B2
(en)
|
2020-12-03 |
2023-06-13 |
University Of Massachusetts |
Gene therapeutics for fibrodysplasia ossificans progressiva
|
|
KR20220082558A
(ko)
|
2020-12-10 |
2022-06-17 |
재단법인 의약바이오컨버젼스연구단 |
면역 증진 활성이 있는 신규 crs 단편 펩타이드 및 이의 용도
|
|
JP2024503402A
(ja)
|
2021-01-12 |
2024-01-25 |
デュレクト コーポレーション |
徐放性薬物送達システム及び関連の方法
|
|
AR124681A1
(es)
|
2021-01-20 |
2023-04-26 |
Abbvie Inc |
Conjugados anticuerpo-fármaco anti-egfr
|
|
WO2022159722A1
(en)
|
2021-01-22 |
2022-07-28 |
University Of Massachusetts |
Use of novel mirna-binding site cassettes for antigen-presenting cell detargeting of transgene expression by raav gene therapy vectors
|
|
US20240141375A1
(en)
|
2021-01-27 |
2024-05-02 |
Umoja Biopharma, Inc. |
Lentivirus for generating cells expressing anti-cd19 chimeric antigen receptor
|
|
EP4330409A4
(en)
|
2021-04-26 |
2025-04-09 |
University of Massachusetts |
GENE THERAPIES FOR STARGARDT'S DISEASE (ABCA4)
|
|
US20240200078A1
(en)
|
2021-11-18 |
2024-06-20 |
Cornell University |
Microrna-dependent mrna switches for tissue-specific mrna-based therapies
|
|
EP4437113A1
(en)
|
2021-11-23 |
2024-10-02 |
University of Massachusetts |
Gene therapy for spinal muscular atrophy
|
|
GB2614309A
(en)
|
2021-12-24 |
2023-07-05 |
Stratosvir Ltd |
Improved vaccinia virus vectors
|
|
US20260008830A1
(en)
|
2022-01-28 |
2026-01-08 |
Fundació Centre De Regulació Genòmica |
Therapeutic cytokines and methods
|
|
WO2023196851A1
(en)
|
2022-04-06 |
2023-10-12 |
President And Fellows Of Harvard College |
Reversing aging of the central nervous system
|
|
EP4525899A1
(en)
|
2022-05-17 |
2025-03-26 |
Umoja Biopharma, Inc. |
Manufacturing viral particles
|
|
IL318505A
(en)
|
2022-08-09 |
2025-03-01 |
Hunan Lonstar Biotech Co Ltd |
Metal-phospholipid complex, metal-phospholipid complex particle, drug-lipid particle, method for preparing same, and use thereof
|
|
US20260048142A1
(en)
|
2022-08-09 |
2026-02-19 |
Hunan Lonstar Biotech Co., Ltd. |
Metal-chelated polyphenol complex nanoparticle, drug-lipid particle, preparation methods for the same, and uses thereof
|
|
CN120882864A
(zh)
|
2022-09-30 |
2025-10-31 |
国立大学法人 东京大学 |
靶向il13ra2的单纯疱疹病毒及抗il13ra2抗体或其抗原结合片段
|
|
TW202434735A
(zh)
|
2022-11-04 |
2024-09-01 |
美商烏莫賈生物製藥股份有限公司 |
展示黏著分子融合的顆粒
|
|
WO2024130212A1
(en)
|
2022-12-16 |
2024-06-20 |
Turnstone Biologics Corp. |
Recombinant vaccinia virus encoding one or more natural killer cell and t lymphocyte inhibitors
|
|
EP4713467A1
(en)
|
2023-05-15 |
2026-03-25 |
Umoja Biopharma, Inc. |
Lentiviral delivery of anti-cd20 chimeric antigen receptors
|
|
WO2025231174A1
(en)
|
2024-04-30 |
2025-11-06 |
Umoja Biopharma, Inc. |
Manufacturing viral particles
|
|
WO2025235604A1
(en)
|
2024-05-08 |
2025-11-13 |
Umoja Biopharma, Inc. |
Fusion protein for use as immune cell engager
|
|
US12171841B1
(en)
|
2024-07-19 |
2024-12-24 |
Imam Mohammad Ibn Saud Islamic University |
Synthesis and characterization of glauconite-based silicate nanorods as anticancer agent
|